geo_accession,title,type,characteristics_ch1,source_name_ch1,sample,series_id,molecule_ch1,extract_protocol_ch1,readsaligned,library_selection,library_source,library_strategy,singlecellprobability,submission_date,data_processing,status,last_update_date,channel_count,organism_ch1,taxid_ch1,platform_id,instrument_model,relation,contact_name,contact_address,contact_city,contact_zip,contact_country,contact_institute
GSM3584918,AD pt1,SRA,"sort population: Live CD45+ CD13- CD3- CD56dim,disease state: atopic dermatitis,barcode: AAATGCA",PBMC CD56dim NK cells,GSM3584918,GSE125916,total RNA,"Cells were sorted directly into lysis buffer containing TCEP according to manufacturer's instructions, vortexed for 30 seconds, and then frozen on dry ice. Total RNA was extracted from 30-100,000 sorted NK cells using the Macherey-Nagel RNA Nucleospin XS kit.,Libraries were constructed using the CloneTech SMARTer cDNA amplification kit with 10 ng of total RNA.",18889411,cDNA,transcriptomic,RNA-Seq,0.07669088743541701,Jan 30 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file, as well as a compiled csv file of RPKMs for each sample",Public on Feb 03 2020,Feb 04 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10848076,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5312174","Madison,R,Mack",425 S. Euclid Ave. CSRB 6649,Saint Louis,,USA,Washington University in St. Louis
GSM3584919,AD pt2,SRA,"sort population: Live CD45+ CD13- CD3- CD56dim,disease state: atopic dermatitis,barcode: AATACGC",PBMC CD56dim NK cells,GSM3584919,GSE125916,total RNA,"Cells were sorted directly into lysis buffer containing TCEP according to manufacturer's instructions, vortexed for 30 seconds, and then frozen on dry ice. Total RNA was extracted from 30-100,000 sorted NK cells using the Macherey-Nagel RNA Nucleospin XS kit.,Libraries were constructed using the CloneTech SMARTer cDNA amplification kit with 10 ng of total RNA.",19169479,cDNA,transcriptomic,RNA-Seq,0.04367132521725048,Jan 30 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file, as well as a compiled csv file of RPKMs for each sample",Public on Feb 03 2020,Feb 04 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10848075,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5312175","Madison,R,Mack",425 S. Euclid Ave. CSRB 6649,Saint Louis,,USA,Washington University in St. Louis
GSM3584922,AD pt3,SRA,"sort population: Live CD45+ CD13- CD3- CD56dim,disease state: atopic dermatitis,barcode: GCCTCCC",PBMC CD56dim NK cells,GSM3584922,GSE125916,total RNA,"Cells were sorted directly into lysis buffer containing TCEP according to manufacturer's instructions, vortexed for 30 seconds, and then frozen on dry ice. Total RNA was extracted from 30-100,000 sorted NK cells using the Macherey-Nagel RNA Nucleospin XS kit.,Libraries were constructed using the CloneTech SMARTer cDNA amplification kit with 10 ng of total RNA.",23714976,cDNA,transcriptomic,RNA-Seq,0.02096983664419325,Jan 30 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file, as well as a compiled csv file of RPKMs for each sample",Public on Feb 03 2020,Feb 04 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10848072,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5312178","Madison,R,Mack",425 S. Euclid Ave. CSRB 6649,Saint Louis,,USA,Washington University in St. Louis
GSM3584925,AD pt4,SRA,"sort population: Live CD45+ CD13- CD3- CD56dim,disease state: atopic dermatitis,barcode: GGTGAAT",PBMC CD56dim NK cells,GSM3584925,GSE125916,total RNA,"Cells were sorted directly into lysis buffer containing TCEP according to manufacturer's instructions, vortexed for 30 seconds, and then frozen on dry ice. Total RNA was extracted from 30-100,000 sorted NK cells using the Macherey-Nagel RNA Nucleospin XS kit.,Libraries were constructed using the CloneTech SMARTer cDNA amplification kit with 10 ng of total RNA.",21483099,cDNA,transcriptomic,RNA-Seq,0.15535600652879603,Jan 30 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file, as well as a compiled csv file of RPKMs for each sample",Public on Feb 03 2020,Feb 04 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10848069,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5312181","Madison,R,Mack",425 S. Euclid Ave. CSRB 6649,Saint Louis,,USA,Washington University in St. Louis
GSM3584926,AD pt5,SRA,"sort population: Live CD45+ CD13- CD3- CD56dim,disease state: atopic dermatitis,barcode: GTATCCT",PBMC CD56dim NK cells,GSM3584926,GSE125916,total RNA,"Cells were sorted directly into lysis buffer containing TCEP according to manufacturer's instructions, vortexed for 30 seconds, and then frozen on dry ice. Total RNA was extracted from 30-100,000 sorted NK cells using the Macherey-Nagel RNA Nucleospin XS kit.,Libraries were constructed using the CloneTech SMARTer cDNA amplification kit with 10 ng of total RNA.",22662180,cDNA,transcriptomic,RNA-Seq,-0.03062975419865034,Jan 30 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file, as well as a compiled csv file of RPKMs for each sample",Public on Feb 03 2020,Feb 04 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10848068,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5312182","Madison,R,Mack",425 S. Euclid Ave. CSRB 6649,Saint Louis,,USA,Washington University in St. Louis
GSM4156922,AD pt1 lesional,SRA,"tissue: skin,type: lesional,disease state: atopic dermatitis",skin,GSM4156922,GSE140227,total RNA,"Skin punch biopsies were performed from lesional and nonlesional skin of atopic dermatitis patients; skin samples were placed in RNA Later and tissue was lysed using a bead homogenizer and RNA was isolated using the RNeasy mini kit (QIAGEN),Libraries were constructed using the CloneTech SMARTer cDNA amplification kit with 10 ng of total RNA.",36124441,cDNA,transcriptomic,RNA-Seq,0.004933970098870212,Nov 12 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file, as well as a compiled csv file of RPKMs for each sample",Public on Nov 13 2019,Nov 20 2019,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13262498,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7129087","Ting-Lin,,Yang","660 S. Euclid Ave., CB 8123",Saint Louis,,USA,Washington University of St Louis
GSM4156923,AD pt1 nonlesional,SRA,"tissue: skin,type: nonlesional,disease state: atopic dermatitis",skin,GSM4156923,GSE140227,total RNA,"Skin punch biopsies were performed from lesional and nonlesional skin of atopic dermatitis patients; skin samples were placed in RNA Later and tissue was lysed using a bead homogenizer and RNA was isolated using the RNeasy mini kit (QIAGEN),Libraries were constructed using the CloneTech SMARTer cDNA amplification kit with 10 ng of total RNA.",24333196,cDNA,transcriptomic,RNA-Seq,0.0030399974371048133,Nov 12 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file, as well as a compiled csv file of RPKMs for each sample",Public on Nov 13 2019,Nov 20 2019,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13262509,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7129088","Ting-Lin,,Yang","660 S. Euclid Ave., CB 8123",Saint Louis,,USA,Washington University of St Louis
GSM4156924,AD pt2 lesional,SRA,"tissue: skin,type: lesional,disease state: atopic dermatitis",skin,GSM4156924,GSE140227,total RNA,"Skin punch biopsies were performed from lesional and nonlesional skin of atopic dermatitis patients; skin samples were placed in RNA Later and tissue was lysed using a bead homogenizer and RNA was isolated using the RNeasy mini kit (QIAGEN),Libraries were constructed using the CloneTech SMARTer cDNA amplification kit with 10 ng of total RNA.",37437764,cDNA,transcriptomic,RNA-Seq,0.022389188741460002,Nov 12 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file, as well as a compiled csv file of RPKMs for each sample",Public on Nov 13 2019,Nov 20 2019,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13262508,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7129089","Ting-Lin,,Yang","660 S. Euclid Ave., CB 8123",Saint Louis,,USA,Washington University of St Louis
GSM4156925,AD pt2 nonlesional,SRA,"tissue: skin,type: nonlesional,disease state: atopic dermatitis",skin,GSM4156925,GSE140227,total RNA,"Skin punch biopsies were performed from lesional and nonlesional skin of atopic dermatitis patients; skin samples were placed in RNA Later and tissue was lysed using a bead homogenizer and RNA was isolated using the RNeasy mini kit (QIAGEN),Libraries were constructed using the CloneTech SMARTer cDNA amplification kit with 10 ng of total RNA.",21076489,cDNA,transcriptomic,RNA-Seq,0.013641579935338604,Nov 12 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file, as well as a compiled csv file of RPKMs for each sample",Public on Nov 13 2019,Nov 20 2019,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13262507,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7129090","Ting-Lin,,Yang","660 S. Euclid Ave., CB 8123",Saint Louis,,USA,Washington University of St Louis
GSM4156926,AD pt3 lesional,SRA,"tissue: skin,type: lesional,disease state: atopic dermatitis",skin,GSM4156926,GSE140227,total RNA,"Skin punch biopsies were performed from lesional and nonlesional skin of atopic dermatitis patients; skin samples were placed in RNA Later and tissue was lysed using a bead homogenizer and RNA was isolated using the RNeasy mini kit (QIAGEN),Libraries were constructed using the CloneTech SMARTer cDNA amplification kit with 10 ng of total RNA.",33156949,cDNA,transcriptomic,RNA-Seq,0.004933970098870212,Nov 12 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file, as well as a compiled csv file of RPKMs for each sample",Public on Nov 13 2019,Nov 20 2019,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13262506,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7129091","Ting-Lin,,Yang","660 S. Euclid Ave., CB 8123",Saint Louis,,USA,Washington University of St Louis
GSM4156927,AD pt3 nonlesional,SRA,"tissue: skin,type: nonlesional,disease state: atopic dermatitis",skin,GSM4156927,GSE140227,total RNA,"Skin punch biopsies were performed from lesional and nonlesional skin of atopic dermatitis patients; skin samples were placed in RNA Later and tissue was lysed using a bead homogenizer and RNA was isolated using the RNeasy mini kit (QIAGEN),Libraries were constructed using the CloneTech SMARTer cDNA amplification kit with 10 ng of total RNA.",35250933,cDNA,transcriptomic,RNA-Seq,-0.0015007869888455977,Nov 12 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file, as well as a compiled csv file of RPKMs for each sample",Public on Nov 13 2019,Nov 20 2019,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13262505,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7129092","Ting-Lin,,Yang","660 S. Euclid Ave., CB 8123",Saint Louis,,USA,Washington University of St Louis
GSM4156928,AD pt4 lesional,SRA,"tissue: skin,type: lesional,disease state: atopic dermatitis",skin,GSM4156928,GSE140227,total RNA,"Skin punch biopsies were performed from lesional and nonlesional skin of atopic dermatitis patients; skin samples were placed in RNA Later and tissue was lysed using a bead homogenizer and RNA was isolated using the RNeasy mini kit (QIAGEN),Libraries were constructed using the CloneTech SMARTer cDNA amplification kit with 10 ng of total RNA.",32376792,cDNA,transcriptomic,RNA-Seq,0.013948430820698776,Nov 12 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file, as well as a compiled csv file of RPKMs for each sample",Public on Nov 13 2019,Nov 20 2019,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13262504,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7129093","Ting-Lin,,Yang","660 S. Euclid Ave., CB 8123",Saint Louis,,USA,Washington University of St Louis
GSM4156929,AD pt4 nonlesional,SRA,"tissue: skin,type: nonlesional,disease state: atopic dermatitis",skin,GSM4156929,GSE140227,total RNA,"Skin punch biopsies were performed from lesional and nonlesional skin of atopic dermatitis patients; skin samples were placed in RNA Later and tissue was lysed using a bead homogenizer and RNA was isolated using the RNeasy mini kit (QIAGEN),Libraries were constructed using the CloneTech SMARTer cDNA amplification kit with 10 ng of total RNA.",20996046,cDNA,transcriptomic,RNA-Seq,0.005691467984520033,Nov 12 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file, as well as a compiled csv file of RPKMs for each sample",Public on Nov 13 2019,Nov 20 2019,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13262503,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7129094","Ting-Lin,,Yang","660 S. Euclid Ave., CB 8123",Saint Louis,,USA,Washington University of St Louis
GSM4156930,AD pt5 lesional,SRA,"tissue: skin,type: lesional,disease state: atopic dermatitis",skin,GSM4156930,GSE140227,total RNA,"Skin punch biopsies were performed from lesional and nonlesional skin of atopic dermatitis patients; skin samples were placed in RNA Later and tissue was lysed using a bead homogenizer and RNA was isolated using the RNeasy mini kit (QIAGEN),Libraries were constructed using the CloneTech SMARTer cDNA amplification kit with 10 ng of total RNA.",31098061,cDNA,transcriptomic,RNA-Seq,0.0017683220223087654,Nov 12 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file, as well as a compiled csv file of RPKMs for each sample",Public on Nov 13 2019,Nov 20 2019,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13262502,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7129095","Ting-Lin,,Yang","660 S. Euclid Ave., CB 8123",Saint Louis,,USA,Washington University of St Louis
GSM4156931,AD pt5 nonlesional,SRA,"tissue: skin,type: nonlesional,disease state: atopic dermatitis",skin,GSM4156931,GSE140227,total RNA,"Skin punch biopsies were performed from lesional and nonlesional skin of atopic dermatitis patients; skin samples were placed in RNA Later and tissue was lysed using a bead homogenizer and RNA was isolated using the RNeasy mini kit (QIAGEN),Libraries were constructed using the CloneTech SMARTer cDNA amplification kit with 10 ng of total RNA.",31443947,cDNA,transcriptomic,RNA-Seq,0.005697326936855922,Nov 12 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file, as well as a compiled csv file of RPKMs for each sample",Public on Nov 13 2019,Nov 20 2019,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13262501,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7129096","Ting-Lin,,Yang","660 S. Euclid Ave., CB 8123",Saint Louis,,USA,Washington University of St Louis
GSM4156932,AD pt6 lesional,SRA,"tissue: skin,type: lesional,disease state: atopic dermatitis",skin,GSM4156932,GSE140227,total RNA,"Skin punch biopsies were performed from lesional and nonlesional skin of atopic dermatitis patients; skin samples were placed in RNA Later and tissue was lysed using a bead homogenizer and RNA was isolated using the RNeasy mini kit (QIAGEN),Libraries were constructed using the CloneTech SMARTer cDNA amplification kit with 10 ng of total RNA.",34664127,cDNA,transcriptomic,RNA-Seq,0.023332519498675507,Nov 12 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file, as well as a compiled csv file of RPKMs for each sample",Public on Nov 13 2019,Nov 20 2019,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13262500,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7129097","Ting-Lin,,Yang","660 S. Euclid Ave., CB 8123",Saint Louis,,USA,Washington University of St Louis
GSM4156933,AD pt6 nonlesional,SRA,"tissue: skin,type: nonlesional,disease state: atopic dermatitis",skin,GSM4156933,GSE140227,total RNA,"Skin punch biopsies were performed from lesional and nonlesional skin of atopic dermatitis patients; skin samples were placed in RNA Later and tissue was lysed using a bead homogenizer and RNA was isolated using the RNeasy mini kit (QIAGEN),Libraries were constructed using the CloneTech SMARTer cDNA amplification kit with 10 ng of total RNA.",30167436,cDNA,transcriptomic,RNA-Seq,0.005162223075182982,Nov 12 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file, as well as a compiled csv file of RPKMs for each sample",Public on Nov 13 2019,Nov 20 2019,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13262499,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7129098","Ting-Lin,,Yang","660 S. Euclid Ave., CB 8123",Saint Louis,,USA,Washington University of St Louis
GSM4160338,ad013,SRA,"tissue: skin,tissue: atopic dermatitis",skin,GSM4160338,GSE140380,total RNA,"4 mm skin biopsies of skin from atopic dermatitis patients or deidentified healthy margin surgical tissue were obtained; skin samples were placed in RNA Later and tissue was lysed using a bead homogenizer followed by RNA isolation using the RNeasy mini kit (QIAGEN),rRNA was depleted using RiboZERO kit (Illumina), mRNA was fragmented in buffer containing 40 mM Tris acetate (pH 8.2), 100 mM potassium acetate, and 30 mM magnesium acetate and heated to 94C for 150 s. mRNA was reverse transcribed to yield cDNA using SuperScript III RT enzyme (Invitrogen, per manufacturerâs instructions) and random hexamers. A second strand reaction was performed to yield dscDNA. cDNA was blunt ended, had an A base added to the 30 ends, and then had Illumina sequencing adapters ligated to the ends. Ligated fragments were then amplified for 12 cycles using primers incorporating unique index tags. Fragments were sequenced on an Illumina HiSeq-3000 using single reads extending 50 bases.",17328070,cDNA,transcriptomic,RNA-Seq,0.006419539904250445,Nov 14 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file",Public on Nov 15 2019,Nov 20 2019,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13283266,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7141081","Brian,,Kim",660 S Euclid Ave,St. Louis,,USA,Washington University in Stl
GSM4160339,ad014,SRA,"tissue: skin,tissue: atopic dermatitis",skin,GSM4160339,GSE140380,total RNA,"4 mm skin biopsies of skin from atopic dermatitis patients or deidentified healthy margin surgical tissue were obtained; skin samples were placed in RNA Later and tissue was lysed using a bead homogenizer followed by RNA isolation using the RNeasy mini kit (QIAGEN),rRNA was depleted using RiboZERO kit (Illumina), mRNA was fragmented in buffer containing 40 mM Tris acetate (pH 8.2), 100 mM potassium acetate, and 30 mM magnesium acetate and heated to 94C for 150 s. mRNA was reverse transcribed to yield cDNA using SuperScript III RT enzyme (Invitrogen, per manufacturerâs instructions) and random hexamers. A second strand reaction was performed to yield dscDNA. cDNA was blunt ended, had an A base added to the 30 ends, and then had Illumina sequencing adapters ligated to the ends. Ligated fragments were then amplified for 12 cycles using primers incorporating unique index tags. Fragments were sequenced on an Illumina HiSeq-3000 using single reads extending 50 bases.",17349620,cDNA,transcriptomic,RNA-Seq,0.007372875927307243,Nov 14 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file",Public on Nov 15 2019,Nov 20 2019,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13283265,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7141082","Brian,,Kim",660 S Euclid Ave,St. Louis,,USA,Washington University in Stl
GSM4160340,ad016,SRA,"tissue: skin,tissue: atopic dermatitis",skin,GSM4160340,GSE140380,total RNA,"4 mm skin biopsies of skin from atopic dermatitis patients or deidentified healthy margin surgical tissue were obtained; skin samples were placed in RNA Later and tissue was lysed using a bead homogenizer followed by RNA isolation using the RNeasy mini kit (QIAGEN),rRNA was depleted using RiboZERO kit (Illumina), mRNA was fragmented in buffer containing 40 mM Tris acetate (pH 8.2), 100 mM potassium acetate, and 30 mM magnesium acetate and heated to 94C for 150 s. mRNA was reverse transcribed to yield cDNA using SuperScript III RT enzyme (Invitrogen, per manufacturerâs instructions) and random hexamers. A second strand reaction was performed to yield dscDNA. cDNA was blunt ended, had an A base added to the 30 ends, and then had Illumina sequencing adapters ligated to the ends. Ligated fragments were then amplified for 12 cycles using primers incorporating unique index tags. Fragments were sequenced on an Illumina HiSeq-3000 using single reads extending 50 bases.",16155654,cDNA,transcriptomic,RNA-Seq,0.005415662210554636,Nov 14 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file",Public on Nov 15 2019,Nov 20 2019,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13283264,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7141083","Brian,,Kim",660 S Euclid Ave,St. Louis,,USA,Washington University in Stl
GSM4160341,ad017,SRA,"tissue: skin,tissue: atopic dermatitis",skin,GSM4160341,GSE140380,total RNA,"4 mm skin biopsies of skin from atopic dermatitis patients or deidentified healthy margin surgical tissue were obtained; skin samples were placed in RNA Later and tissue was lysed using a bead homogenizer followed by RNA isolation using the RNeasy mini kit (QIAGEN),rRNA was depleted using RiboZERO kit (Illumina), mRNA was fragmented in buffer containing 40 mM Tris acetate (pH 8.2), 100 mM potassium acetate, and 30 mM magnesium acetate and heated to 94C for 150 s. mRNA was reverse transcribed to yield cDNA using SuperScript III RT enzyme (Invitrogen, per manufacturerâs instructions) and random hexamers. A second strand reaction was performed to yield dscDNA. cDNA was blunt ended, had an A base added to the 30 ends, and then had Illumina sequencing adapters ligated to the ends. Ligated fragments were then amplified for 12 cycles using primers incorporating unique index tags. Fragments were sequenced on an Illumina HiSeq-3000 using single reads extending 50 bases.",12892408,cDNA,transcriptomic,RNA-Seq,0.007664013182680885,Nov 14 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file",Public on Nov 15 2019,Nov 20 2019,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13283262,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7141084","Brian,,Kim",660 S Euclid Ave,St. Louis,,USA,Washington University in Stl
GSM4160342,mx0007,SRA,"tissue: skin,tissue: healthy margin",skin,GSM4160342,GSE140380,total RNA,"4 mm skin biopsies of skin from atopic dermatitis patients or deidentified healthy margin surgical tissue were obtained; skin samples were placed in RNA Later and tissue was lysed using a bead homogenizer followed by RNA isolation using the RNeasy mini kit (QIAGEN),rRNA was depleted using RiboZERO kit (Illumina), mRNA was fragmented in buffer containing 40 mM Tris acetate (pH 8.2), 100 mM potassium acetate, and 30 mM magnesium acetate and heated to 94C for 150 s. mRNA was reverse transcribed to yield cDNA using SuperScript III RT enzyme (Invitrogen, per manufacturerâs instructions) and random hexamers. A second strand reaction was performed to yield dscDNA. cDNA was blunt ended, had an A base added to the 30 ends, and then had Illumina sequencing adapters ligated to the ends. Ligated fragments were then amplified for 12 cycles using primers incorporating unique index tags. Fragments were sequenced on an Illumina HiSeq-3000 using single reads extending 50 bases.",13955648,cDNA,transcriptomic,RNA-Seq,0.006018874214360803,Nov 14 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file",Public on Nov 15 2019,Nov 20 2019,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13283261,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7141085","Brian,,Kim",660 S Euclid Ave,St. Louis,,USA,Washington University in Stl
GSM4160343,mx0014,SRA,"tissue: skin,tissue: healthy margin",skin,GSM4160343,GSE140380,total RNA,"4 mm skin biopsies of skin from atopic dermatitis patients or deidentified healthy margin surgical tissue were obtained; skin samples were placed in RNA Later and tissue was lysed using a bead homogenizer followed by RNA isolation using the RNeasy mini kit (QIAGEN),rRNA was depleted using RiboZERO kit (Illumina), mRNA was fragmented in buffer containing 40 mM Tris acetate (pH 8.2), 100 mM potassium acetate, and 30 mM magnesium acetate and heated to 94C for 150 s. mRNA was reverse transcribed to yield cDNA using SuperScript III RT enzyme (Invitrogen, per manufacturerâs instructions) and random hexamers. A second strand reaction was performed to yield dscDNA. cDNA was blunt ended, had an A base added to the 30 ends, and then had Illumina sequencing adapters ligated to the ends. Ligated fragments were then amplified for 12 cycles using primers incorporating unique index tags. Fragments were sequenced on an Illumina HiSeq-3000 using single reads extending 50 bases.",11269923,cDNA,transcriptomic,RNA-Seq,0.00030543266923445096,Nov 14 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file",Public on Nov 15 2019,Nov 20 2019,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13283259,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7141086","Brian,,Kim",660 S Euclid Ave,St. Louis,,USA,Washington University in Stl
GSM4160344,mx0018,SRA,"tissue: skin,tissue: healthy margin",skin,GSM4160344,GSE140380,total RNA,"4 mm skin biopsies of skin from atopic dermatitis patients or deidentified healthy margin surgical tissue were obtained; skin samples were placed in RNA Later and tissue was lysed using a bead homogenizer followed by RNA isolation using the RNeasy mini kit (QIAGEN),rRNA was depleted using RiboZERO kit (Illumina), mRNA was fragmented in buffer containing 40 mM Tris acetate (pH 8.2), 100 mM potassium acetate, and 30 mM magnesium acetate and heated to 94C for 150 s. mRNA was reverse transcribed to yield cDNA using SuperScript III RT enzyme (Invitrogen, per manufacturerâs instructions) and random hexamers. A second strand reaction was performed to yield dscDNA. cDNA was blunt ended, had an A base added to the 30 ends, and then had Illumina sequencing adapters ligated to the ends. Ligated fragments were then amplified for 12 cycles using primers incorporating unique index tags. Fragments were sequenced on an Illumina HiSeq-3000 using single reads extending 50 bases.",19045918,cDNA,transcriptomic,RNA-Seq,0.002409276641268436,Nov 14 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file",Public on Nov 15 2019,Nov 20 2019,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13283258,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7141087","Brian,,Kim",660 S Euclid Ave,St. Louis,,USA,Washington University in Stl
GSM4160345,mx0019,SRA,"tissue: skin,tissue: healthy margin",skin,GSM4160345,GSE140380,total RNA,"4 mm skin biopsies of skin from atopic dermatitis patients or deidentified healthy margin surgical tissue were obtained; skin samples were placed in RNA Later and tissue was lysed using a bead homogenizer followed by RNA isolation using the RNeasy mini kit (QIAGEN),rRNA was depleted using RiboZERO kit (Illumina), mRNA was fragmented in buffer containing 40 mM Tris acetate (pH 8.2), 100 mM potassium acetate, and 30 mM magnesium acetate and heated to 94C for 150 s. mRNA was reverse transcribed to yield cDNA using SuperScript III RT enzyme (Invitrogen, per manufacturerâs instructions) and random hexamers. A second strand reaction was performed to yield dscDNA. cDNA was blunt ended, had an A base added to the 30 ends, and then had Illumina sequencing adapters ligated to the ends. Ligated fragments were then amplified for 12 cycles using primers incorporating unique index tags. Fragments were sequenced on an Illumina HiSeq-3000 using single reads extending 50 bases.",14259964,cDNA,transcriptomic,RNA-Seq,0.005435102957519284,Nov 14 2019,"Sequences were aligned with STAR v2.0.4b,Gene counts were determined with Subread:featureCount v1.4.5,Transcript abundance was determined with Sailfish v0.6.3,Sequence performace was assessed with RSeQC v2.3,Genome_build: GRCh38,Supplementary_files_format_and_content: Processed data files are the counts tables from Subread:featureCount for each sample as a text file",Public on Nov 15 2019,Nov 20 2019,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13283257,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7141088","Brian,,Kim",660 S Euclid Ave,St. Louis,,USA,Washington University in Stl
GSM4207124,S13_S5,SRA,"ptid: 2007,timepoint: BL,treatment: Cerdulatinib,tissue: skin,disease state: Lesional,patient diagnosis: Mild-to-Moderate Atopic Dermatitis",Skin biopsy,GSM4207124,GSE141570,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",39181323,cDNA,transcriptomic,RNA-Seq,0.0036040442150919727,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 12 2020,Nov 12 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497073,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280865","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207125,S10_S2,SRA,"ptid: 2005,timepoint: D14,treatment: Cerdulatinib,tissue: skin,disease state: Lesional,patient diagnosis: Mild-to-Moderate Atopic Dermatitis",Skin biopsy,GSM4207125,GSE141570,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",43330224,cDNA,transcriptomic,RNA-Seq,0.0026578810596024913,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 12 2020,Nov 12 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497072,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280866","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207126,S7_S7,SRA,"ptid: 2004,timepoint: BL,treatment: Cerdulatinib,tissue: skin,disease state: Lesional,patient diagnosis: Mild-to-Moderate Atopic Dermatitis",Skin biopsy,GSM4207126,GSE141570,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",45576039,cDNA,transcriptomic,RNA-Seq,0.003982124217556637,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 12 2020,Nov 12 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497071,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280867","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207127,S3_S3,SRA,"ptid: 2002,timepoint: BL,treatment: Cerdulatinib,tissue: skin,disease state: Lesional,patient diagnosis: Mild-to-Moderate Atopic Dermatitis",Skin biopsy,GSM4207127,GSE141570,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",39977119,cDNA,transcriptomic,RNA-Seq,0.0024958545143712193,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 12 2020,Nov 12 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497070,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280868","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207128,S16_S8,SRA,"ptid: 2008,timepoint: D14,treatment: Cerdulatinib,tissue: skin,disease state: Lesional,patient diagnosis: Mild-to-Moderate Atopic Dermatitis",Skin biopsy,GSM4207128,GSE141570,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",31998826,cDNA,transcriptomic,RNA-Seq,0.0028742700420445275,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 12 2020,Nov 12 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497069,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280869","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207129,S8_S8,SRA,"ptid: 2004,timepoint: D14,treatment: Cerdulatinib,tissue: skin,disease state: Lesional,patient diagnosis: Mild-to-Moderate Atopic Dermatitis",Skin biopsy,GSM4207129,GSE141570,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",44777540,cDNA,transcriptomic,RNA-Seq,0.002339166180371591,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 12 2020,Nov 12 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497068,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280870","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207130,S12_S4,SRA,"ptid: 2006,timepoint: D14,treatment: Cerdulatinib,tissue: skin,disease state: Lesional,patient diagnosis: Mild-to-Moderate Atopic Dermatitis",Skin biopsy,GSM4207130,GSE141570,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",42102621,cDNA,transcriptomic,RNA-Seq,0.002110913204058821,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 12 2020,Nov 12 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497067,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280871","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207131,S19_S11,SRA,"ptid: 2010,timepoint: BL,treatment: Cerdulatinib,tissue: skin,disease state: Lesional,patient diagnosis: Mild-to-Moderate Atopic Dermatitis",Skin biopsy,GSM4207131,GSE141570,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",30973936,cDNA,transcriptomic,RNA-Seq,0.0024839905205004853,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 12 2020,Nov 12 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497066,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280872","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207132,S11_S3,SRA,"ptid: 2006,timepoint: BL,treatment: Cerdulatinib,tissue: skin,disease state: Lesional,patient diagnosis: Mild-to-Moderate Atopic Dermatitis",Skin biopsy,GSM4207132,GSE141570,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",41544848,cDNA,transcriptomic,RNA-Seq,0.002339166180371591,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 12 2020,Nov 12 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497065,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280873","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207133,S15_S7,SRA,"ptid: 2008,timepoint: BL,treatment: Cerdulatinib,tissue: skin,disease state: Lesional,patient diagnosis: Mild-to-Moderate Atopic Dermatitis",Skin biopsy,GSM4207133,GSE141570,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",38480038,cDNA,transcriptomic,RNA-Seq,0.0026460170657317574,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 12 2020,Nov 12 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497064,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280874","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207134,S4_S4,SRA,"ptid: 2002,timepoint: D14,treatment: Cerdulatinib,tissue: skin,disease state: Lesional,patient diagnosis: Mild-to-Moderate Atopic Dermatitis",Skin biopsy,GSM4207134,GSE141570,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",46873899,cDNA,transcriptomic,RNA-Seq,0.0027122434968132555,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 12 2020,Nov 12 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497063,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280875","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207135,S9_S1,SRA,"ptid: 2005,timepoint: BL,treatment: Cerdulatinib,tissue: skin,disease state: Lesional,patient diagnosis: Mild-to-Moderate Atopic Dermatitis",Skin biopsy,GSM4207135,GSE141570,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",39272831,cDNA,transcriptomic,RNA-Seq,0.0014545622951492542,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 12 2020,Nov 12 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497062,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280876","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207136,S14_S6,SRA,"ptid: 2007,timepoint: D14,treatment: Cerdulatinib,tissue: skin,disease state: Lesional,patient diagnosis: Mild-to-Moderate Atopic Dermatitis",Skin biopsy,GSM4207136,GSE141570,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",51203253,cDNA,transcriptomic,RNA-Seq,0.0036040442150919727,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 12 2020,Nov 12 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497061,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280877","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207137,S18,SRA,"ptid: 2009,timepoint: D14,treatment: Cerdulatinib,tissue: skin,disease state: Lesional,patient diagnosis: Mild-to-Moderate Atopic Dermatitis",Skin biopsy,GSM4207137,GSE141570,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",31748719,cDNA,transcriptomic,RNA-Seq,0.003982124217556637,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 12 2020,Nov 12 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497060,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280878","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207138,S17,SRA,"ptid: 2009,timepoint: BL,treatment: Cerdulatinib,tissue: skin,disease state: Lesional,patient diagnosis: Mild-to-Moderate Atopic Dermatitis",Skin biopsy,GSM4207138,GSE141570,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",30415478,cDNA,transcriptomic,RNA-Seq,0.002339166180371591,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 12 2020,Nov 12 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497059,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280879","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207139,S20,SRA,"ptid: 2010,timepoint: D14,treatment: Cerdulatinib,tissue: skin,disease state: Lesional,patient diagnosis: Mild-to-Moderate Atopic Dermatitis",Skin biopsy,GSM4207139,GSE141570,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",32593418,cDNA,transcriptomic,RNA-Seq,0.0027122434968132555,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 12 2020,Nov 12 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497058,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280880","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207140,1_S1_L002_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 114-506,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207140,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",39632209,cDNA,transcriptomic,RNA-Seq,0.0030456547681888707,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497125,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280881","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207141,10_S3_L008_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 114-514,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207141,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",46181676,cDNA,transcriptomic,RNA-Seq,0.0028520652571238526,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497124,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280882","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207142,101_S18_L003_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-505,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207142,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",44456829,cDNA,transcriptomic,RNA-Seq,0.0008528964771861732,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497123,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280883","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207143,102_S19_L003_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-505,timepoint: Week2,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207143,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",44576568,cDNA,transcriptomic,RNA-Seq,0.0010692854596282095,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497122,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280884","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207144,104_S20_L003_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-506,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207144,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",48141783,cDNA,transcriptomic,RNA-Seq,0.001972950171777661,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497182,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280885","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207145,105_S21_L003_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-506,timepoint: Week2,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207145,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",42544573,cDNA,transcriptomic,RNA-Seq,0.002189339154219697,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497181,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280886","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207146,106_S22_L003_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-507,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207146,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",38662420,cDNA,transcriptomic,RNA-Seq,0.0023460274882193253,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497180,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280887","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207147,108_S23_L003_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-507,timepoint: Week2,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207147,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",43223537,cDNA,transcriptomic,RNA-Seq,0.002117774511906555,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497179,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280888","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207148,11_S4_L008_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 114-514,timepoint: Week2,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207148,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",59160672,cDNA,transcriptomic,RNA-Seq,0.0014373601962515772,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497178,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280889","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207149,111_S24_L003_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-508,timepoint: Week2,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207149,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",36552236,cDNA,transcriptomic,RNA-Seq,0.003982124217556637,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497177,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280890","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207150,112_S25_L004_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-509,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207150,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",40153658,cDNA,transcriptomic,RNA-Seq,0.004382097445222394,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497176,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280891","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207151,113_S26_L004_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-509,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207151,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",43490132,cDNA,transcriptomic,RNA-Seq,0.0027244430158926336,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497162,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280892","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207152,114_S27_L004_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-509,timepoint: Week2,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207152,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",46511385,cDNA,transcriptomic,RNA-Seq,0.005067028333047226,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497161,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280893","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207153,115_S28_L004_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-510,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207153,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",48628136,cDNA,transcriptomic,RNA-Seq,0.002339166180371591,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497160,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280894","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207154,117_S29_L004_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-510,timepoint: Week2,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207154,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",42489304,cDNA,transcriptomic,RNA-Seq,0.0037657352351146006,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497159,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280895","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207155,119_S30_L004_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-511,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207155,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",44753346,cDNA,transcriptomic,RNA-Seq,0.002339166180371591,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497158,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280896","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207156,12_S5_L008_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 201-502,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207156,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",51316164,cDNA,transcriptomic,RNA-Seq,-0.00019048325487080813,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497157,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280897","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207157,121_S31_L004_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-512,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207157,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",37237018,cDNA,transcriptomic,RNA-Seq,0.002189339154219697,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497156,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280898","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207158,122_S32_L004_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-512,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207158,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",41159829,cDNA,transcriptomic,RNA-Seq,0.0028889664341892425,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497175,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280899","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207159,123_S33_L005_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-513,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207159,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",38922297,cDNA,transcriptomic,RNA-Seq,0.0028742700420445275,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497174,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280900","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207160,124_S34_L005_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-513,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207160,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",35775388,cDNA,transcriptomic,RNA-Seq,0.001972950171777661,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497173,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280901","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207161,126_S35_L005_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-514,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207161,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",45030359,cDNA,transcriptomic,RNA-Seq,0.0023460274882193253,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497172,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280902","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207162,127_S37_L005_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-514,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207162,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",48381505,cDNA,transcriptomic,RNA-Seq,0.0010692854596282095,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497171,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280903","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207163,128_S1_L001_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-514,timepoint: Week2,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207163,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",37169492,cDNA,transcriptomic,RNA-Seq,0.000501590644688995,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497170,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280904","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207164,129_S38_L005_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-515,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207164,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",50144375,cDNA,transcriptomic,RNA-Seq,0.007873305163216235,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497169,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280905","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207165,13_S6_L008_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 201-502,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207165,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",32987090,cDNA,transcriptomic,RNA-Seq,0.0039642296564350735,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497155,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280906","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207166,130_S39_L005_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-515,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207166,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",40353888,cDNA,transcriptomic,RNA-Seq,0.003982124217556637,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497154,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280907","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207167,131_S2_L001_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-515,timepoint: Week2,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207167,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",31252085,cDNA,transcriptomic,RNA-Seq,0.0027122434968132555,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497153,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280908","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207168,132_S3_L001_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-516,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207168,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",27415098,cDNA,transcriptomic,RNA-Seq,0.002189339154219697,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497152,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280909","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207169,133_S40_L005_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-516,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207169,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",39663098,cDNA,transcriptomic,RNA-Seq,0.002339166180371591,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497151,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280910","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207170,134_S4_L001_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 242-505,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207170,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",39334850,cDNA,transcriptomic,RNA-Seq,0.0027122434968132555,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497150,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280911","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207171,135_S5_L001_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 242-505,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207171,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",46994592,cDNA,transcriptomic,RNA-Seq,0.0041831169100487765,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497149,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280912","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207172,14_S7_L008_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 201-502,timepoint: Week2,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207172,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",32242776,cDNA,transcriptomic,RNA-Seq,0.0035861496539704094,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497148,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280913","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207173,15_S8_L008_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 201-503,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207173,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",39262669,cDNA,transcriptomic,RNA-Seq,0.003264602376465528,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497147,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280914","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207174,16_S9_L003_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 201-503,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207174,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",34608419,cDNA,transcriptomic,RNA-Seq,0.11522095473227212,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497146,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280915","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207175,17_S3_L002_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 201-503,timepoint: Week2,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207175,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",36871173,cDNA,transcriptomic,RNA-Seq,0.003832297191404743,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497145,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280916","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207176,18_S12_L003_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 201-504,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207176,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",35244425,cDNA,transcriptomic,RNA-Seq,0.002122777197929555,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497144,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280917","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207177,2_S10_L003_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 114-506,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207177,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",33575988,cDNA,transcriptomic,RNA-Seq,0.0025624164706613615,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497143,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280918","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207178,21_S13_L003_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 201-505,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207178,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",34540864,cDNA,transcriptomic,RNA-Seq,0.0037657352351146006,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497142,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280919","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207179,22_S14_L003_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 201-505,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207179,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",32184479,cDNA,transcriptomic,RNA-Seq,0.002189339154219697,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497141,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280920","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207180,23_S15_L003_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 201-505,timepoint: Week2,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207180,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",40758025,cDNA,transcriptomic,RNA-Seq,0.003982124217556637,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497140,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280921","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207181,24_S16_L003_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 201-506,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207181,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",42611741,cDNA,transcriptomic,RNA-Seq,0.004315535488932252,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497134,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280922","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207182,25_S17_L004_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 201-506,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207182,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",36503185,cDNA,transcriptomic,RNA-Seq,0.004531924471374288,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497133,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280923","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207183,26_S18_L004_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 201-506,timepoint: Week2,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207183,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",39244472,cDNA,transcriptomic,RNA-Seq,0.002110913204058821,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497132,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280924","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207184,27_S4_L002_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 201-507,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207184,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",43747062,cDNA,transcriptomic,RNA-Seq,0.003832297191404743,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497139,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280925","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207185,28_S5_L002_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 201-507,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207185,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",38792609,cDNA,transcriptomic,RNA-Seq,0.002339166180371591,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497138,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280926","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207186,3_S1_L008_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 114-508,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207186,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",35266782,cDNA,transcriptomic,RNA-Seq,0.0037997062381384663,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497137,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280927","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207187,30_S6_L001_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 201-508,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207187,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",34026430,cDNA,transcriptomic,RNA-Seq,0.004288975102916805,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497136,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280928","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207188,31_S19_L004_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 201-508,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207188,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",39265489,cDNA,transcriptomic,RNA-Seq,0.004838775356734456,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497135,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280929","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207189,32_S6_L002_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 201-508,timepoint: Week2,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207189,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",38741621,cDNA,transcriptomic,RNA-Seq,0.0023015162560296103,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497131,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280930","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207190,33_S20_L004_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 201-509,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207190,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",42182200,cDNA,transcriptomic,RNA-Seq,0.004531924471374288,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497130,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280931","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207191,34_S21_L004_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 201-509,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207191,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",35009093,cDNA,transcriptomic,RNA-Seq,0.004382097445222394,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497129,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280932","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207192,35_S22_L004_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 242-501,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207192,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",40583265,cDNA,transcriptomic,RNA-Seq,0.0024839905205004853,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497128,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280933","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207193,36_S7_L001_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 242-501,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207193,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",62779522,cDNA,transcriptomic,RNA-Seq,0.0024839905205004853,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497127,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280934","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207194,37_S7_L002_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 242-501,timepoint: Week2,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207194,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",38425409,cDNA,transcriptomic,RNA-Seq,0.0037538712412438667,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497126,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280935","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207195,39_S8_L001_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 242-502,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207195,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",45242114,cDNA,transcriptomic,RNA-Seq,0.004303671495061518,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497074,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280936","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207196,40_S23_L006_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 242-502,timepoint: Week2,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207196,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",48616720,cDNA,transcriptomic,RNA-Seq,0.004303671495061518,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497121,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280937","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207197,41_S23_L004_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 242-504,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207197,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",40221742,cDNA,transcriptomic,RNA-Seq,0.07923486843649498,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497120,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280938","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207198,42_S24_L004_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 242-504,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207198,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",31983490,cDNA,transcriptomic,RNA-Seq,0.0026607134578764723,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497119,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280939","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207199,43_S25_L005_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 242-504,timepoint: Week2,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207199,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",35380673,cDNA,transcriptomic,RNA-Seq,0.0010692854596282095,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497118,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280940","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207200,45_S26_L005_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 247-501,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207200,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",36532870,cDNA,transcriptomic,RNA-Seq,0.0014545622951492542,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497117,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280941","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207201,46_S27_L005_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 247-501,timepoint: Week2,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207201,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",34231983,cDNA,transcriptomic,RNA-Seq,0.0009194584334763158,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497116,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280942","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207202,47_S28_L005_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 250-501,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207202,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",44238788,cDNA,transcriptomic,RNA-Seq,0.004151012070635645,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497115,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280943","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207203,48_S29_L005_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 250-501,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207203,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",36033976,cDNA,transcriptomic,RNA-Seq,0.07635594701513923,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497114,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280944","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207204,5_S2_L008_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 114-508,timepoint: Week2,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207204,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",46399985,cDNA,transcriptomic,RNA-Seq,0.00394953326429036,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497113,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280945","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207205,50_S30_L005_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 250-502,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207205,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",36436974,cDNA,transcriptomic,RNA-Seq,0.000691205457163546,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497112,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280946","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207206,51_S31_L005_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 250-502,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207206,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",43065351,cDNA,transcriptomic,RNA-Seq,0.0011597473625463415,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497111,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280947","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207207,52_S32_L005_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 250-502,timepoint: ET,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207207,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",39770327,cDNA,transcriptomic,RNA-Seq,0.002110913204058821,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497110,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280948","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207208,53_S33_L006_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 250-503,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207208,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",36647966,cDNA,transcriptomic,RNA-Seq,0.003982124217556637,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497109,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280949","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207209,54_S34_L006_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 250-503,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207209,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",37472983,cDNA,transcriptomic,RNA-Seq,0.003982124217556637,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497108,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280950","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207210,55_S35_L006_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 250-503,timepoint: Week2,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207210,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",31998874,cDNA,transcriptomic,RNA-Seq,0.003832297191404743,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497106,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280951","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207211,56_S36_L006_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 250-504,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207211,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",41809791,cDNA,transcriptomic,RNA-Seq,0.001972950171777661,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497105,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280952","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207212,57_S37_L006_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 250-504,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207212,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",40791818,cDNA,transcriptomic,RNA-Seq,0.04012682232434672,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497104,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280953","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207213,58_S38_L006_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 250-504,timepoint: Week2,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207213,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",40681574,cDNA,transcriptomic,RNA-Seq,0.002189339154219697,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497103,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280954","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207214,6_S11_L003_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 114-509,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207214,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",34168977,cDNA,transcriptomic,RNA-Seq,0.002869267356021528,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497107,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280955","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207215,60_S39_L006_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 251-501,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207215,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",39341291,cDNA,transcriptomic,RNA-Seq,0.06562581870992046,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497102,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280956","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207216,61_S40_L006_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 251-501,timepoint: Week2,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207216,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",35537719,cDNA,transcriptomic,RNA-Seq,0.0027244430158926336,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497101,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280957","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207217,62_S8_L002_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 251-502,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207217,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",34034180,cDNA,transcriptomic,RNA-Seq,0.0027122434968132555,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497100,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280958","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207218,63_S49_L008_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 251-502,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207218,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",32329716,cDNA,transcriptomic,RNA-Seq,0.0025624164706613615,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497099,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280959","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207219,64_S50_L008_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 251-502,timepoint: Week2,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207219,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",39030426,cDNA,transcriptomic,RNA-Seq,0.003982124217556637,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497098,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280960","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207220,65_S51_L008_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 251-503,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207220,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",38173511,cDNA,transcriptomic,RNA-Seq,0.005067028333047226,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497097,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280961","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207221,66_S52_L008_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 251-503,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207221,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",39002752,cDNA,transcriptomic,RNA-Seq,0.08800719076421544,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497096,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280962","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207222,67_S53_L008_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 251-503,timepoint: Week2,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207222,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",38529544,cDNA,transcriptomic,RNA-Seq,0.003832297191404743,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497095,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280963","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207223,68_S54_L008_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 251-504,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207223,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",33231460,cDNA,transcriptomic,RNA-Seq,0.003832297191404743,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497094,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280964","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207224,69_S55_L008_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 251-504,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207224,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",37061253,cDNA,transcriptomic,RNA-Seq,0.003832297191404743,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497093,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280965","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207225,70_S56_L008_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 251-504,timepoint: Week2,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207225,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",36363417,cDNA,transcriptomic,RNA-Seq,0.0025624164706613615,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497092,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280966","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207226,71_S1_L001_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 263-501,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207226,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",40956007,cDNA,transcriptomic,RNA-Seq,0.0026578810596024913,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497091,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280967","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207227,72_S2_L001_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 263-501,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207227,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",40190956,cDNA,transcriptomic,RNA-Seq,0.0027244430158926336,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497090,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280968","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207228,73_S3_L001_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 264-501,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207228,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",46737562,cDNA,transcriptomic,RNA-Seq,0.003982124217556637,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497089,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280969","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207229,74_S41_L007_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 264-501,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207229,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",37935771,cDNA,transcriptomic,RNA-Seq,0.08970356055138903,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497088,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280970","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207230,75_S4_L001_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 264-501,timepoint: Week2,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207230,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",46727523,cDNA,transcriptomic,RNA-Seq,0.002110913204058821,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497087,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280971","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207231,76_S5_L001_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 264-502,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207231,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",40748000,cDNA,transcriptomic,RNA-Seq,0.003832297191404743,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497086,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280972","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207232,78_S6_L001_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 264-502,timepoint: Week2,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207232,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",43104864,cDNA,transcriptomic,RNA-Seq,0.0033876552326499365,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497085,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280973","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207233,79_S42_L007_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 264-503,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207233,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",38877447,cDNA,transcriptomic,RNA-Seq,0.002189339154219697,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497084,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280974","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207234,8_S2_L002_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 114-509,timepoint: Week2,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207234,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",30179586,cDNA,transcriptomic,RNA-Seq,0.004139148076764911,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497083,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280975","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207235,80_S43_L007_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 264-503,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207235,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",40174355,cDNA,transcriptomic,RNA-Seq,-0.0018974808949951752,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497082,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280976","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207236,80A_S44_L007_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 264-503,timepoint: Week2,treatment: SB414 2%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207236,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",35179455,cDNA,transcriptomic,RNA-Seq,0.06509071484824752,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497081,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280977","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207237,81_S45_L007_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 264-504,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207237,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",35616324,cDNA,transcriptomic,RNA-Seq,0.000691205457163546,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497080,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280978","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207238,82_S46_L007_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 264-504,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207238,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",39728170,cDNA,transcriptomic,RNA-Seq,0.06359258115119139,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497079,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280979","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207239,84_S7_L001_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 264-505,timepoint: Baseline,treatment: SB414 2%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207239,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",41809099,cDNA,transcriptomic,RNA-Seq,0.004649065779378967,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497078,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280980","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207240,87_S47_L007_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 264-506,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207240,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",34086552,cDNA,transcriptomic,RNA-Seq,0.0038616323091725706,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497077,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280981","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207241,88_S8_L001_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-501,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207241,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",39358534,cDNA,transcriptomic,RNA-Seq,0.003832297191404743,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497076,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280982","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207242,89_S9_L002_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-501,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207242,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",41266034,cDNA,transcriptomic,RNA-Seq,0.0036159082089627067,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497168,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280983","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207243,9_S36_L005_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 114-514,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207243,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",43826321,cDNA,transcriptomic,RNA-Seq,0.0662497346900999,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497167,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280984","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207244,90_S10_L002_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-501,timepoint: Week2,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207244,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",44891364,cDNA,transcriptomic,RNA-Seq,0.0036159082089627067,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497166,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280985","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207245,91_S11_L002_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-502,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207245,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",38321148,cDNA,transcriptomic,RNA-Seq,0.0021000601535148596,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497165,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280986","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207246,92_S12_L002_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-502,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207246,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",41307877,cDNA,transcriptomic,RNA-Seq,0.001376136344988378,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497164,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280987","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207247,93_S13_L002_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-502,timepoint: Week2,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207247,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",48269343,cDNA,transcriptomic,RNA-Seq,0.0028742700420445275,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497163,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280988","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207248,94_S14_L002_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-503,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207248,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",43234917,cDNA,transcriptomic,RNA-Seq,0.004151012070635645,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497248,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280989","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207249,95_S15_L002_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-503,timepoint: Baseline,treatment: SB414 6%,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207249,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",39760814,cDNA,transcriptomic,RNA-Seq,0.004367401053077681,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497247,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280990","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207250,97_S16_L002_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-504,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207250,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",48323540,cDNA,transcriptomic,RNA-Seq,0.001972950171777661,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497246,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280991","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207251,98_S48_L007_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-504,timepoint: Baseline,treatment: Placebo,tissue: skin,tissue disease state: Non-Les",Skin biopsy,GSM4207251,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",30289660,cDNA,transcriptomic,RNA-Seq,0.001972950171777661,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497250,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280992","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4207252,99_S17_L003_R1_001,SRA,"patient diagnosis: Atopic Dermatitis,ptid: 265-504,timepoint: Week2,treatment: Placebo,tissue: skin,tissue disease state: Les",Skin biopsy,GSM4207252,GSE141571,total RNA,"Total RNA was extracted from skin biopsy samples using Qiagen miRNeasy Mini kit.,The libraries were generated using TruSeq Stranded mRNA Library Prep kit following manufactory protocol. Briefly, mRNA was first extracted from 240ng of total RNA using oligo-dT magnetic beads and fragmented at high temperature. A cDNA library was then prepared from the fragemented mRNA by revervse transcription, second strand synthesis and ligation of specific adapters.,Next generation sequencing was performed on Illumina Hiseq 4000 with single-ended 100 red cycles. Image analysis and bases calling was conducted in real-time by the Illumina analysis pipeline.",46828589,cDNA,transcriptomic,RNA-Seq,0.0036159082089627067,Dec 06 2019,"RNA-seq sample quality was assessed using FastQC and MultiQC.,Samples were aligned to human reference genome based on STAR RNA-sequencing aligner and sequencing reads were assigned to genomic features by featureCounts.,Genomic features with 0 counts in more than 20% of the samples were filtered out.,Data was then transfromed to log2-counts per million by voom-transform.,Fold changes (FCHs) vs. baseline were estimated and hypothesis testing was conducted with contrasts under the general framework for linear models in limma package. P-values were adjusted using the Benjamini-Hochberg procedure, which controls False Discovery Rate (FDR).,Genome_build: GRCh38,Supplementary_files_format_and_content: log2-counts per million",Public on Nov 23 2020,Nov 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13497249,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7280993","Ana,,Pavel",One Gustave L. Levy Place,New York,,USA,Icahn School of Medicine at Mount Sinai
GSM4367887,DC_RmAD_1,SRA,"bacterial isolate: Roseomonas mucosa,bacteria source: Atopic dermatitis",Dendritic cell,GSM4367887,GSE146184,total RNA,"After 24 hours, RNA was extracted using RNAeasy kit from QIAGEN per manufacturers recommendations.,RNA-seq libraries were created in triplicate for all cell types using Illumina TruSeq Stranded TotalRNA Library Prep, pooled, and sequenced on a HiSeq4000 producing paired-end 150 base-pair reads.",21285581,cDNA,transcriptomic,RNA-Seq,0.003071963832143914,Mar 02 2020,"Reads were trimmed using cutadapt to remove adaptor sequences and low quality bases.,After trimming, reads were aligned to the human hg38 reference genome and Gencode release28 using STAR v2.5.2b.,RSEM v1.3.0  was used for gene-level expression quantification.,Genome_build: hg38,Supplementary_files_format_and_content: raw counts and FPKM",Public on Sep 23 2020,Sep 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN14257697,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7826708","Ian,A,Myles","9000 Rockville Pike, BLD 29B, Rm 5NN24",Bethesda,,USA,NIH
GSM4367888,DC_RmAD_2,SRA,"bacterial isolate: Roseomonas mucosa,bacteria source: Atopic dermatitis",Dendritic cell,GSM4367888,GSE146184,total RNA,"After 24 hours, RNA was extracted using RNAeasy kit from QIAGEN per manufacturers recommendations.,RNA-seq libraries were created in triplicate for all cell types using Illumina TruSeq Stranded TotalRNA Library Prep, pooled, and sequenced on a HiSeq4000 producing paired-end 150 base-pair reads.",21923922,cDNA,transcriptomic,RNA-Seq,0.003607067693816853,Mar 02 2020,"Reads were trimmed using cutadapt to remove adaptor sequences and low quality bases.,After trimming, reads were aligned to the human hg38 reference genome and Gencode release28 using STAR v2.5.2b.,RSEM v1.3.0  was used for gene-level expression quantification.,Genome_build: hg38,Supplementary_files_format_and_content: raw counts and FPKM",Public on Sep 23 2020,Sep 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN14257696,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7826709","Ian,A,Myles","9000 Rockville Pike, BLD 29B, Rm 5NN24",Bethesda,,USA,NIH
GSM4367889,DC_RmAD_3,SRA,"bacterial isolate: Roseomonas mucosa,bacteria source: Atopic dermatitis",Dendritic cell,GSM4367889,GSE146184,total RNA,"After 24 hours, RNA was extracted using RNAeasy kit from QIAGEN per manufacturers recommendations.,RNA-seq libraries were created in triplicate for all cell types using Illumina TruSeq Stranded TotalRNA Library Prep, pooled, and sequenced on a HiSeq4000 producing paired-end 150 base-pair reads.",19218813,cDNA,transcriptomic,RNA-Seq,0.0035114635093360033,Mar 02 2020,"Reads were trimmed using cutadapt to remove adaptor sequences and low quality bases.,After trimming, reads were aligned to the human hg38 reference genome and Gencode release28 using STAR v2.5.2b.,RSEM v1.3.0  was used for gene-level expression quantification.,Genome_build: hg38,Supplementary_files_format_and_content: raw counts and FPKM",Public on Sep 23 2020,Sep 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN14257695,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7826710","Ian,A,Myles","9000 Rockville Pike, BLD 29B, Rm 5NN24",Bethesda,,USA,NIH
GSM4367893,DC_SAAD_1,SRA,"bacterial isolate: Staphylococcus aureus,bacteria source: Atopic dermatitis",Dendritic cell,GSM4367893,GSE146184,total RNA,"After 24 hours, RNA was extracted using RNAeasy kit from QIAGEN per manufacturers recommendations.,RNA-seq libraries were created in triplicate for all cell types using Illumina TruSeq Stranded TotalRNA Library Prep, pooled, and sequenced on a HiSeq4000 producing paired-end 150 base-pair reads.",25243256,cDNA,transcriptomic,RNA-Seq,0.003607067693816853,Mar 02 2020,"Reads were trimmed using cutadapt to remove adaptor sequences and low quality bases.,After trimming, reads were aligned to the human hg38 reference genome and Gencode release28 using STAR v2.5.2b.,RSEM v1.3.0  was used for gene-level expression quantification.,Genome_build: hg38,Supplementary_files_format_and_content: raw counts and FPKM",Public on Sep 23 2020,Sep 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN14257691,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7826714","Ian,A,Myles","9000 Rockville Pike, BLD 29B, Rm 5NN24",Bethesda,,USA,NIH
GSM4367894,DC_SAAD_2,SRA,"bacterial isolate: Staphylococcus aureus,bacteria source: Atopic dermatitis",Dendritic cell,GSM4367894,GSE146184,total RNA,"After 24 hours, RNA was extracted using RNAeasy kit from QIAGEN per manufacturers recommendations.,RNA-seq libraries were created in triplicate for all cell types using Illumina TruSeq Stranded TotalRNA Library Prep, pooled, and sequenced on a HiSeq4000 producing paired-end 150 base-pair reads.",22637477,cDNA,transcriptomic,RNA-Seq,0.003071963832143914,Mar 02 2020,"Reads were trimmed using cutadapt to remove adaptor sequences and low quality bases.,After trimming, reads were aligned to the human hg38 reference genome and Gencode release28 using STAR v2.5.2b.,RSEM v1.3.0  was used for gene-level expression quantification.,Genome_build: hg38,Supplementary_files_format_and_content: raw counts and FPKM",Public on Sep 23 2020,Sep 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN14257690,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7826715","Ian,A,Myles","9000 Rockville Pike, BLD 29B, Rm 5NN24",Bethesda,,USA,NIH
GSM4367895,DC_SAAD_3,SRA,"bacterial isolate: Staphylococcus aureus,bacteria source: Atopic dermatitis",Dendritic cell,GSM4367895,GSE146184,total RNA,"After 24 hours, RNA was extracted using RNAeasy kit from QIAGEN per manufacturers recommendations.,RNA-seq libraries were created in triplicate for all cell types using Illumina TruSeq Stranded TotalRNA Library Prep, pooled, and sequenced on a HiSeq4000 producing paired-end 150 base-pair reads.",22263362,cDNA,transcriptomic,RNA-Seq,0.003071963832143914,Mar 02 2020,"Reads were trimmed using cutadapt to remove adaptor sequences and low quality bases.,After trimming, reads were aligned to the human hg38 reference genome and Gencode release28 using STAR v2.5.2b.,RSEM v1.3.0  was used for gene-level expression quantification.,Genome_build: hg38,Supplementary_files_format_and_content: raw counts and FPKM",Public on Sep 23 2020,Sep 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN14257738,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7826716","Ian,A,Myles","9000 Rockville Pike, BLD 29B, Rm 5NN24",Bethesda,,USA,NIH
GSM4367902,FB_RmAD_1,SRA,"bacterial isolate: Roseomonas mucosa,bacteria source: Atopic dermatitis",Primary fibroblast,GSM4367902,GSE146184,total RNA,"After 24 hours, RNA was extracted using RNAeasy kit from QIAGEN per manufacturers recommendations.,RNA-seq libraries were created in triplicate for all cell types using Illumina TruSeq Stranded TotalRNA Library Prep, pooled, and sequenced on a HiSeq4000 producing paired-end 150 base-pair reads.",17174043,cDNA,transcriptomic,RNA-Seq,0.006695017479167309,Mar 02 2020,"Reads were trimmed using cutadapt to remove adaptor sequences and low quality bases.,After trimming, reads were aligned to the human hg38 reference genome and Gencode release28 using STAR v2.5.2b.,RSEM v1.3.0  was used for gene-level expression quantification.,Genome_build: hg38,Supplementary_files_format_and_content: raw counts and FPKM",Public on Sep 23 2020,Sep 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN14257731,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7826723","Ian,A,Myles","9000 Rockville Pike, BLD 29B, Rm 5NN24",Bethesda,,USA,NIH
GSM4367903,FB_RmAD_2,SRA,"bacterial isolate: Roseomonas mucosa,bacteria source: Atopic dermatitis",Primary fibroblast,GSM4367903,GSE146184,total RNA,"After 24 hours, RNA was extracted using RNAeasy kit from QIAGEN per manufacturers recommendations.,RNA-seq libraries were created in triplicate for all cell types using Illumina TruSeq Stranded TotalRNA Library Prep, pooled, and sequenced on a HiSeq4000 producing paired-end 150 base-pair reads.",17950644,cDNA,transcriptomic,RNA-Seq,0.006695017479167309,Mar 02 2020,"Reads were trimmed using cutadapt to remove adaptor sequences and low quality bases.,After trimming, reads were aligned to the human hg38 reference genome and Gencode release28 using STAR v2.5.2b.,RSEM v1.3.0  was used for gene-level expression quantification.,Genome_build: hg38,Supplementary_files_format_and_content: raw counts and FPKM",Public on Sep 23 2020,Sep 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN14257730,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7826724","Ian,A,Myles","9000 Rockville Pike, BLD 29B, Rm 5NN24",Bethesda,,USA,NIH
GSM4367904,FB_RmAD_3,SRA,"bacterial isolate: Roseomonas mucosa,bacteria source: Atopic dermatitis",Primary fibroblast,GSM4367904,GSE146184,total RNA,"After 24 hours, RNA was extracted using RNAeasy kit from QIAGEN per manufacturers recommendations.,RNA-seq libraries were created in triplicate for all cell types using Illumina TruSeq Stranded TotalRNA Library Prep, pooled, and sequenced on a HiSeq4000 producing paired-end 150 base-pair reads.",18321836,cDNA,transcriptomic,RNA-Seq,0.0052885310264738205,Mar 02 2020,"Reads were trimmed using cutadapt to remove adaptor sequences and low quality bases.,After trimming, reads were aligned to the human hg38 reference genome and Gencode release28 using STAR v2.5.2b.,RSEM v1.3.0  was used for gene-level expression quantification.,Genome_build: hg38,Supplementary_files_format_and_content: raw counts and FPKM",Public on Sep 23 2020,Sep 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN14257689,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7826725","Ian,A,Myles","9000 Rockville Pike, BLD 29B, Rm 5NN24",Bethesda,,USA,NIH
GSM4367908,FB_SAAD_1,SRA,"bacterial isolate: Staphylococcus aureus,bacteria source: Atopic dermatitis",Primary fibroblast,GSM4367908,GSE146184,total RNA,"After 24 hours, RNA was extracted using RNAeasy kit from QIAGEN per manufacturers recommendations.,RNA-seq libraries were created in triplicate for all cell types using Illumina TruSeq Stranded TotalRNA Library Prep, pooled, and sequenced on a HiSeq4000 producing paired-end 150 base-pair reads.",22924319,cDNA,transcriptomic,RNA-Seq,0.0047442569870967885,Mar 02 2020,"Reads were trimmed using cutadapt to remove adaptor sequences and low quality bases.,After trimming, reads were aligned to the human hg38 reference genome and Gencode release28 using STAR v2.5.2b.,RSEM v1.3.0  was used for gene-level expression quantification.,Genome_build: hg38,Supplementary_files_format_and_content: raw counts and FPKM",Public on Sep 23 2020,Sep 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN14257684,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7826729","Ian,A,Myles","9000 Rockville Pike, BLD 29B, Rm 5NN24",Bethesda,,USA,NIH
GSM4367909,FB_SAAD_2,SRA,"bacterial isolate: Staphylococcus aureus,bacteria source: Atopic dermatitis",Primary fibroblast,GSM4367909,GSE146184,total RNA,"After 24 hours, RNA was extracted using RNAeasy kit from QIAGEN per manufacturers recommendations.,RNA-seq libraries were created in triplicate for all cell types using Illumina TruSeq Stranded TotalRNA Library Prep, pooled, and sequenced on a HiSeq4000 producing paired-end 150 base-pair reads.",20838166,cDNA,transcriptomic,RNA-Seq,0.0047442569870967885,Mar 02 2020,"Reads were trimmed using cutadapt to remove adaptor sequences and low quality bases.,After trimming, reads were aligned to the human hg38 reference genome and Gencode release28 using STAR v2.5.2b.,RSEM v1.3.0  was used for gene-level expression quantification.,Genome_build: hg38,Supplementary_files_format_and_content: raw counts and FPKM",Public on Sep 23 2020,Sep 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN14257683,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7826730","Ian,A,Myles","9000 Rockville Pike, BLD 29B, Rm 5NN24",Bethesda,,USA,NIH
GSM4367910,FB_SAAD_3,SRA,"bacterial isolate: Staphylococcus aureus,bacteria source: Atopic dermatitis",Primary fibroblast,GSM4367910,GSE146184,total RNA,"After 24 hours, RNA was extracted using RNAeasy kit from QIAGEN per manufacturers recommendations.,RNA-seq libraries were created in triplicate for all cell types using Illumina TruSeq Stranded TotalRNA Library Prep, pooled, and sequenced on a HiSeq4000 producing paired-end 150 base-pair reads.",18377725,cDNA,transcriptomic,RNA-Seq,0.006321940162725645,Mar 02 2020,"Reads were trimmed using cutadapt to remove adaptor sequences and low quality bases.,After trimming, reads were aligned to the human hg38 reference genome and Gencode release28 using STAR v2.5.2b.,RSEM v1.3.0  was used for gene-level expression quantification.,Genome_build: hg38,Supplementary_files_format_and_content: raw counts and FPKM",Public on Sep 23 2020,Sep 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN14257682,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7826731","Ian,A,Myles","9000 Rockville Pike, BLD 29B, Rm 5NN24",Bethesda,,USA,NIH
GSM4367917,KC_RmAD_1,SRA,"bacterial isolate: Roseomonas mucosa,bacteria source: Atopic dermatitis",Primary keratinocyte,GSM4367917,GSE146184,total RNA,"After 24 hours, RNA was extracted using RNAeasy kit from QIAGEN per manufacturers recommendations.,RNA-seq libraries were created in triplicate for all cell types using Illumina TruSeq Stranded TotalRNA Library Prep, pooled, and sequenced on a HiSeq4000 producing paired-end 150 base-pair reads.",21311122,cDNA,transcriptomic,RNA-Seq,0.004799809019303505,Mar 02 2020,"Reads were trimmed using cutadapt to remove adaptor sequences and low quality bases.,After trimming, reads were aligned to the human hg38 reference genome and Gencode release28 using STAR v2.5.2b.,RSEM v1.3.0  was used for gene-level expression quantification.,Genome_build: hg38,Supplementary_files_format_and_content: raw counts and FPKM",Public on Sep 23 2020,Sep 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN14257674,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7826738","Ian,A,Myles","9000 Rockville Pike, BLD 29B, Rm 5NN24",Bethesda,,USA,NIH
GSM4367918,KC_RmAD_2,SRA,"bacterial isolate: Roseomonas mucosa,bacteria source: Atopic dermatitis",Primary keratinocyte,GSM4367918,GSE146184,total RNA,"After 24 hours, RNA was extracted using RNAeasy kit from QIAGEN per manufacturers recommendations.,RNA-seq libraries were created in triplicate for all cell types using Illumina TruSeq Stranded TotalRNA Library Prep, pooled, and sequenced on a HiSeq4000 producing paired-end 150 base-pair reads.",21354714,cDNA,transcriptomic,RNA-Seq,0.0057195205842009,Mar 02 2020,"Reads were trimmed using cutadapt to remove adaptor sequences and low quality bases.,After trimming, reads were aligned to the human hg38 reference genome and Gencode release28 using STAR v2.5.2b.,RSEM v1.3.0  was used for gene-level expression quantification.,Genome_build: hg38,Supplementary_files_format_and_content: raw counts and FPKM",Public on Sep 23 2020,Sep 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN14257673,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7826739","Ian,A,Myles","9000 Rockville Pike, BLD 29B, Rm 5NN24",Bethesda,,USA,NIH
GSM4367919,KC_RmAD_3,SRA,"bacterial isolate: Roseomonas mucosa,bacteria source: Atopic dermatitis",Primary keratinocyte,GSM4367919,GSE146184,total RNA,"After 24 hours, RNA was extracted using RNAeasy kit from QIAGEN per manufacturers recommendations.,RNA-seq libraries were created in triplicate for all cell types using Illumina TruSeq Stranded TotalRNA Library Prep, pooled, and sequenced on a HiSeq4000 producing paired-end 150 base-pair reads.",19396797,cDNA,transcriptomic,RNA-Seq,0.0033551159153430415,Mar 02 2020,"Reads were trimmed using cutadapt to remove adaptor sequences and low quality bases.,After trimming, reads were aligned to the human hg38 reference genome and Gencode release28 using STAR v2.5.2b.,RSEM v1.3.0  was used for gene-level expression quantification.,Genome_build: hg38,Supplementary_files_format_and_content: raw counts and FPKM",Public on Sep 23 2020,Sep 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN14257672,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7826740","Ian,A,Myles","9000 Rockville Pike, BLD 29B, Rm 5NN24",Bethesda,,USA,NIH
GSM4367923,KC_SAAD_1,SRA,"bacterial isolate: Staphylococcus aureus,bacteria source: Atopic dermatitis",Primary keratinocyte,GSM4367923,GSE146184,total RNA,"After 24 hours, RNA was extracted using RNAeasy kit from QIAGEN per manufacturers recommendations.,RNA-seq libraries were created in triplicate for all cell types using Illumina TruSeq Stranded TotalRNA Library Prep, pooled, and sequenced on a HiSeq4000 producing paired-end 150 base-pair reads.",24185655,cDNA,transcriptomic,RNA-Seq,0.003350955865649502,Mar 02 2020,"Reads were trimmed using cutadapt to remove adaptor sequences and low quality bases.,After trimming, reads were aligned to the human hg38 reference genome and Gencode release28 using STAR v2.5.2b.,RSEM v1.3.0  was used for gene-level expression quantification.,Genome_build: hg38,Supplementary_files_format_and_content: raw counts and FPKM",Public on Sep 23 2020,Sep 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN14257668,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7826744","Ian,A,Myles","9000 Rockville Pike, BLD 29B, Rm 5NN24",Bethesda,,USA,NIH
GSM4367924,KC_SAAD_2,SRA,"bacterial isolate: Staphylococcus aureus,bacteria source: Atopic dermatitis",Primary keratinocyte,GSM4367924,GSE146184,total RNA,"After 24 hours, RNA was extracted using RNAeasy kit from QIAGEN per manufacturers recommendations.,RNA-seq libraries were created in triplicate for all cell types using Illumina TruSeq Stranded TotalRNA Library Prep, pooled, and sequenced on a HiSeq4000 producing paired-end 150 base-pair reads.",20469970,cDNA,transcriptomic,RNA-Seq,0.006023307885544263,Mar 02 2020,"Reads were trimmed using cutadapt to remove adaptor sequences and low quality bases.,After trimming, reads were aligned to the human hg38 reference genome and Gencode release28 using STAR v2.5.2b.,RSEM v1.3.0  was used for gene-level expression quantification.,Genome_build: hg38,Supplementary_files_format_and_content: raw counts and FPKM",Public on Sep 23 2020,Sep 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN14257667,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7826745","Ian,A,Myles","9000 Rockville Pike, BLD 29B, Rm 5NN24",Bethesda,,USA,NIH
GSM4367925,KC_SAAD_3,SRA,"bacterial isolate: Staphylococcus aureus,bacteria source: Atopic dermatitis",Primary keratinocyte,GSM4367925,GSE146184,total RNA,"After 24 hours, RNA was extracted using RNAeasy kit from QIAGEN per manufacturers recommendations.,RNA-seq libraries were created in triplicate for all cell types using Illumina TruSeq Stranded TotalRNA Library Prep, pooled, and sequenced on a HiSeq4000 producing paired-end 150 base-pair reads.",23000745,cDNA,transcriptomic,RNA-Seq,0.0028066818262724724,Mar 02 2020,"Reads were trimmed using cutadapt to remove adaptor sequences and low quality bases.,After trimming, reads were aligned to the human hg38 reference genome and Gencode release28 using STAR v2.5.2b.,RSEM v1.3.0  was used for gene-level expression quantification.,Genome_build: hg38,Supplementary_files_format_and_content: raw counts and FPKM",Public on Sep 23 2020,Sep 23 2020,1,Homo sapiens,9606,GPL20301,Illumina HiSeq 4000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN14257717,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7826746","Ian,A,Myles","9000 Rockville Pike, BLD 29B, Rm 5NN24",Bethesda,,USA,NIH
GSM4758555,Patient_1_AL_m0,SRA,"patient id: Patient_1,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758555,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",28220995,cDNA,transcriptomic,RNA-Seq,0.0029227079491172194,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949006,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042452","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758556,Patient_1_AN_m0,SRA,"patient id: Patient_1,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758556,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",21419652,cDNA,transcriptomic,RNA-Seq,0.003072646450425595,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949005,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042453","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758557,Patient_2_AN_m0,SRA,"patient id: Patient_2,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758557,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",24086720,cDNA,transcriptomic,RNA-Seq,0.0024240829983608737,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949004,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042454","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758558,Patient_2_AL_m0,SRA,"patient id: Patient_2,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758558,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",27805269,cDNA,transcriptomic,RNA-Seq,0.0021466499748614043,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949008,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042455","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758559,Patient_3_AN_m0,SRA,"patient id: Patient_3,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758559,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",27150021,cDNA,transcriptomic,RNA-Seq,0.0030011435359991556,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949007,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042456","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758560,Patient_3_AL_m0,SRA,"patient id: Patient_3,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758560,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",27787057,cDNA,transcriptomic,RNA-Seq,0.002537431113596176,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949003,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042457","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758561,Patient_4_AL_m0,SRA,"patient id: Patient_4,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758561,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",24774937,cDNA,transcriptomic,RNA-Seq,0.00428131322166301,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949002,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042458","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758562,Patient_4_AN_m0,SRA,"patient id: Patient_4,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758562,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",25529297,cDNA,transcriptomic,RNA-Seq,0.002709014120354972,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949001,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042459","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758563,Patient_5_AL_m0,SRA,"patient id: Patient_5,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758563,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",29399752,cDNA,transcriptomic,RNA-Seq,0.00405306024535024,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949000,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042460","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758564,Patient_5_AN_m0,SRA,"patient id: Patient_5,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758564,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",29388100,cDNA,transcriptomic,RNA-Seq,0.001226309318836484,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948999,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042461","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758565,Patient_6_AL_m0,SRA,"patient id: Patient_6,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758565,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",26786313,cDNA,transcriptomic,RNA-Seq,0.0037462093599900715,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948998,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042462","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758566,Patient_6_AN_m0,SRA,"patient id: Patient_6,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758566,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",22396326,cDNA,transcriptomic,RNA-Seq,0.003011432500919626,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948997,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042463","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758567,Patient_7_AL_m0,SRA,"patient id: Patient_7,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758567,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",27662603,cDNA,transcriptomic,RNA-Seq,0.0032372858075921927,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948996,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042464","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758568,Patient_7_AN_m0,SRA,"patient id: Patient_7,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758568,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",31508488,cDNA,transcriptomic,RNA-Seq,0.002390331846711837,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948995,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042465","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758569,Patient_8_AL_m0,SRA,"patient id: Patient_8,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758569,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",27087223,cDNA,transcriptomic,RNA-Seq,0.000691205457163546,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949031,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042466","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758570,Patient_8_AN_m0,SRA,"patient id: Patient_8,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758570,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",23122578,cDNA,transcriptomic,RNA-Seq,0.002270296691738238,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949030,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042467","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758571,Patient_9_AN_m0,SRA,"patient id: Patient_9,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758571,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",27309727,cDNA,transcriptomic,RNA-Seq,0.004768066742967325,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949029,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042468","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758572,Patient_9_AL_m0,SRA,"patient id: Patient_9,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758572,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",28539004,cDNA,transcriptomic,RNA-Seq,0.0053031706046402635,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949028,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042469","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758573,Patient_10_AN_m0,SRA,"patient id: Patient_10,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758573,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",24482428,cDNA,transcriptomic,RNA-Seq,0.004367401053077681,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949027,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042470","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758574,Patient_10_AL_m0,SRA,"patient id: Patient_10,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758574,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",29832838,cDNA,transcriptomic,RNA-Seq,0.00015969621734068687,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949026,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042471","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758575,Patient_11_AL_m0,SRA,"patient id: Patient_11,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758575,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",29870934,cDNA,transcriptomic,RNA-Seq,0.0027244430158926336,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949025,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042472","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758576,Patient_11_AN_m0,SRA,"patient id: Patient_11,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758576,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",24748605,cDNA,transcriptomic,RNA-Seq,0.001279749911932173,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949024,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042473","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758577,Patient_12_AN_m0,SRA,"patient id: Patient_12,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758577,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",22872328,cDNA,transcriptomic,RNA-Seq,0.000691205457163546,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949023,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042474","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758578,Patient_12_AL_m0,SRA,"patient id: Patient_12,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758578,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",28291567,cDNA,transcriptomic,RNA-Seq,0.0006662201000983588,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948976,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042475","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758579,Patient_13_AL_m0,SRA,"patient id: Patient_13,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758579,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",23960658,cDNA,transcriptomic,RNA-Seq,0.000744646050259235,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948975,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042476","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758580,Patient_13_AN_m0,SRA,"patient id: Patient_13,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758580,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",23853023,cDNA,transcriptomic,RNA-Seq,0.002189339154219697,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948970,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042477","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758581,Patient_14_AL_m0,SRA,"patient id: Patient_14,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758581,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",27612512,cDNA,transcriptomic,RNA-Seq,0.0031251087057822787,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948969,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042478","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758582,Patient_14_AN_m0,SRA,"patient id: Patient_14,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758582,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",18411468,cDNA,transcriptomic,RNA-Seq,0.004136021999335755,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948968,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042479","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758583,Patient_15_AN_m0,SRA,"patient id: Patient_15,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758583,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",24798409,cDNA,transcriptomic,RNA-Seq,0.004431140247814904,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948974,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042480","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758584,Patient_15_AL_m0,SRA,"patient id: Patient_15,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758584,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",26636086,cDNA,transcriptomic,RNA-Seq,0.0028366201177025476,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948973,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042481","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758585,Patient_16_AL_m0,SRA,"patient id: Patient_16,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758585,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",25118128,cDNA,transcriptomic,RNA-Seq,0.0031251087057822787,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948972,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042482","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758586,Patient_16_AN_m0,SRA,"patient id: Patient_16,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758586,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",31968940,cDNA,transcriptomic,RNA-Seq,0.0018552279850388978,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948971,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042483","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758587,Patient_17_AL_m0,SRA,"patient id: Patient_17,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758587,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",29846421,cDNA,transcriptomic,RNA-Seq,0.0010692854596282095,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948967,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042532","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758588,Patient_17_AN_m0,SRA,"patient id: Patient_17,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758588,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",32783480,cDNA,transcriptomic,RNA-Seq,0.000744646050259235,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948966,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042533","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758589,Patient_18_AN_m0,SRA,"patient id: Patient_18,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758589,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",27027850,cDNA,transcriptomic,RNA-Seq,0.004517228079229575,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948965,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042534","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758590,Patient_18_AL_m0,SRA,"patient id: Patient_18,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758590,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",15812234,cDNA,transcriptomic,RNA-Seq,0.008080982128417916,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948994,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042535","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758591,Patient_19_AL_m0,SRA,"patient id: Patient_19,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758591,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",24446036,cDNA,transcriptomic,RNA-Seq,0.004011542079417336,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948993,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042536","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758592,Patient_19_AN_m0,SRA,"patient id: Patient_19,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758592,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",24388064,cDNA,transcriptomic,RNA-Seq,0.004367401053077681,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948992,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042537","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758593,Patient_20_AN_m0,SRA,"patient id: Patient_20,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758593,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",25530284,cDNA,transcriptomic,RNA-Seq,0.0024763286392466897,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948991,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042538","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758594,Patient_20_AL_m0,SRA,"patient id: Patient_20,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758594,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",23808234,cDNA,transcriptomic,RNA-Seq,0.0005929520917388332,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948990,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042539","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758595,Patient_21_AN_m0,SRA,"patient id: Patient_21,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758595,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",25654041,cDNA,transcriptomic,RNA-Seq,0.000691205457163546,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948989,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042540","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758596,Patient_21_AL_m0,SRA,"patient id: Patient_21,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758596,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",21503372,cDNA,transcriptomic,RNA-Seq,0.0008033825589734596,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948988,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042541","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758597,Patient_22_AL_m0,SRA,"patient id: Patient_22,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758597,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",24317420,cDNA,transcriptomic,RNA-Seq,0.0033903503863297255,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948987,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042542","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758598,Patient_22_AN_m0,SRA,"patient id: Patient_22,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758598,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",22635971,cDNA,transcriptomic,RNA-Seq,0.001961086177906927,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948986,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042543","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758599,Patient_23_AL_m0,SRA,"patient id: Patient_23,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758599,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",28050829,cDNA,transcriptomic,RNA-Seq,0.0011814625614381235,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948985,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042544","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758600,Patient_23_AN_m0,SRA,"patient id: Patient_23,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758600,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",18816572,cDNA,transcriptomic,RNA-Seq,0.004081364674340356,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948984,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042545","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758601,Patient_24_AN_m0,SRA,"patient id: Patient_24,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758601,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",27316342,cDNA,transcriptomic,RNA-Seq,-0.00021838378512397695,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948983,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042546","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758602,Patient_24_AL_m0,SRA,"patient id: Patient_24,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758602,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",23126590,cDNA,transcriptomic,RNA-Seq,0.000923890938271828,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948982,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042547","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758603,Patient_25_AN_m0,SRA,"patient id: Patient_25,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758603,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",28511922,cDNA,transcriptomic,RNA-Seq,0.0023015162560296103,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948981,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042586","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758604,Patient_25_AL_m0,SRA,"patient id: Patient_25,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758604,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",28419515,cDNA,transcriptomic,RNA-Seq,0.002387604087444282,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948980,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042587","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758605,Patient_26_AL_m0,SRA,"patient id: Patient_26,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758605,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",30406383,cDNA,transcriptomic,RNA-Seq,0.002533107460528897,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948979,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042588","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758606,Patient_26_AN_m0,SRA,"patient id: Patient_26,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758606,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",19601631,cDNA,transcriptomic,RNA-Seq,0.000691205457163546,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948978,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042589","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758607,Patient_27_AN_m0,SRA,"patient id: Patient_27,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758607,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",26323438,cDNA,transcriptomic,RNA-Seq,0.0036040442150919727,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15948977,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042590","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758608,Patient_27_AL_m0,SRA,"patient id: Patient_27,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758608,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",25219444,cDNA,transcriptomic,RNA-Seq,0.002642905222605889,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949022,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042591","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758609,Patient_28_AL_m0,SRA,"patient id: Patient_28,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758609,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",28895597,cDNA,transcriptomic,RNA-Seq,0.003097520332334298,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949021,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042592","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758610,Patient_28_AN_m0,SRA,"patient id: Patient_28,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758610,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",29438635,cDNA,transcriptomic,RNA-Seq,0.0028742700420445275,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949020,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042593","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758611,Patient_29_AL_m0,SRA,"patient id: Patient_29,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758611,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",25812634,cDNA,transcriptomic,RNA-Seq,0.0031251087057822787,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949019,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042594","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758612,Patient_29_AN_m0,SRA,"patient id: Patient_29,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758612,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",21843073,cDNA,transcriptomic,RNA-Seq,0.001967405086848811,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949018,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042595","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758613,Patient_30_AL_m0,SRA,"patient id: Patient_30,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758613,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",26479593,cDNA,transcriptomic,RNA-Seq,0.0031251087057822787,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949017,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042596","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758614,Patient_30_AN_m0,SRA,"patient id: Patient_30,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758614,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",23867239,cDNA,transcriptomic,RNA-Seq,0.0031578456395679067,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949016,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042597","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758615,Patient_31_AN_m0,SRA,"patient id: Patient_31,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758615,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",27228091,cDNA,transcriptomic,RNA-Seq,0.0028366201177025476,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949015,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042598","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758616,Patient_31_AL_m0,SRA,"patient id: Patient_31,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758616,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",11414990,cDNA,transcriptomic,RNA-Seq,0.06572143091515112,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949014,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042599","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758617,Patient_32_AN_m0,SRA,"patient id: Patient_32,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758617,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",25709675,cDNA,transcriptomic,RNA-Seq,0.0027111108952734934,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949013,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042600","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758618,Patient_32_AL_m0,SRA,"patient id: Patient_32,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758618,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",25913828,cDNA,transcriptomic,RNA-Seq,0.001961086177906927,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949012,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042601","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758619,Patient_33_AN_m0,SRA,"patient id: Patient_33,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758619,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",18536623,cDNA,transcriptomic,RNA-Seq,0.0005163930739464648,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949011,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042484","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758620,Patient_33_AL_m0,SRA,"patient id: Patient_33,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758620,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",36774636,cDNA,transcriptomic,RNA-Seq,0.0019833072067112455,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949010,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042485","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758621,Patient_34_AN_m0,SRA,"patient id: Patient_34,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758621,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",23589814,cDNA,transcriptomic,RNA-Seq,0.00038878707659888953,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949009,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042486","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758622,Patient_34_AL_m0,SRA,"patient id: Patient_34,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758622,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",23510359,cDNA,transcriptomic,RNA-Seq,0.0025289269733654914,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949049,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042487","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758623,Patient_35_AL_m0,SRA,"patient id: Patient_35,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758623,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",34747890,cDNA,transcriptomic,RNA-Seq,0.003982124217556637,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949048,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042488","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758624,Patient_35_AN_m0,SRA,"patient id: Patient_35,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758624,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",36271980,cDNA,transcriptomic,RNA-Seq,0.0027244430158926336,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949047,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042489","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758625,Patient_36_AL_m0,SRA,"patient id: Patient_36,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758625,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",30599814,cDNA,transcriptomic,RNA-Seq,-0.00037540764433225304,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949046,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042490","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758626,Patient_36_AN_m0,SRA,"patient id: Patient_36,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758626,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",31562147,cDNA,transcriptomic,RNA-Seq,-0.0001837324481658325,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949045,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042491","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758627,Patient_37_AN_m0,SRA,"patient id: Patient_37,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758627,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",19370511,cDNA,transcriptomic,RNA-Seq,0.0029425980805140046,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949044,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042492","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758628,Patient_37_AL_m0,SRA,"patient id: Patient_37,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758628,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",26249127,cDNA,transcriptomic,RNA-Seq,0.0023015162560296103,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949043,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042493","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758629,Patient_38_AL_m0,SRA,"patient id: Patient_38,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758629,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",33557472,cDNA,transcriptomic,RNA-Seq,0.0055842227533501165,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949042,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042494","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758630,Patient_38_AN_m0,SRA,"patient id: Patient_38,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758630,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",26386696,cDNA,transcriptomic,RNA-Seq,-0.0004213693002840714,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949041,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042495","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758631,Patient_39_AL_m0,SRA,"patient id: Patient_39,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758631,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",21030203,cDNA,transcriptomic,RNA-Seq,0.0009040295379386543,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949040,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042496","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758632,Patient_40_AN_m0,SRA,"patient id: Patient_40,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758632,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",31495436,cDNA,transcriptomic,RNA-Seq,0.0005163930739464648,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949039,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042497","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758633,Patient_40_AL_m0,SRA,"patient id: Patient_40,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758633,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",25252607,cDNA,transcriptomic,RNA-Seq,0.00816374562863185,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949038,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042498","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758634,Patient_41_AN_m0,SRA,"patient id: Patient_41,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758634,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",30015807,cDNA,transcriptomic,RNA-Seq,0.00207326327971684,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949037,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042499","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758635,Patient_41_AL_m0,SRA,"patient id: Patient_41,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758635,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",31365181,cDNA,transcriptomic,RNA-Seq,0.0011331540933411197,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949036,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042554","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758636,Patient_42_AN_m0,SRA,"patient id: Patient_42,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758636,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",19446496,cDNA,transcriptomic,RNA-Seq,0.0018334801805593515,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949035,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042555","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758637,Patient_42_AL_m0,SRA,"patient id: Patient_42,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758637,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",41225245,cDNA,transcriptomic,RNA-Seq,0.002110913204058821,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949034,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042556","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758638,Patient_43_AN_m0,SRA,"patient id: Patient_43,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758638,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",23663254,cDNA,transcriptomic,RNA-Seq,9.869191188793025e-06,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949109,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042557","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758639,Patient_43_AL_m0,SRA,"patient id: Patient_43,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758639,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",22379119,cDNA,transcriptomic,RNA-Seq,0.001152143914584598,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949108,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042558","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758640,Patient_44_AL_m0,SRA,"patient id: Patient_44,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758640,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",28511468,cDNA,transcriptomic,RNA-Seq,0.001961086177906927,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949107,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042559","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758641,Patient_44_AN_m0,SRA,"patient id: Patient_44,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758641,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",29303579,cDNA,transcriptomic,RNA-Seq,0.002451343282181504,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949102,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042560","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758642,Patient_45_AL_m0,SRA,"patient id: Patient_45,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758642,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",32069611,cDNA,transcriptomic,RNA-Seq,0.002110913204058821,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949101,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042561","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758643,Patient_45_AN_m0,SRA,"patient id: Patient_45,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758643,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",26841589,cDNA,transcriptomic,RNA-Seq,0.0019833072067112455,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949106,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042562","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758644,Patient_46_AL_m0,SRA,"patient id: Patient_46,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758644,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",26812228,cDNA,transcriptomic,RNA-Seq,0.0022054330789070264,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949105,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042563","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758645,Patient_47_AN_m0,SRA,"patient id: Patient_47,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758645,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",36882924,cDNA,transcriptomic,RNA-Seq,0.0032462147569464334,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949104,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042564","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758646,Patient_47_AL_m0,SRA,"patient id: Patient_47,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758646,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",31222338,cDNA,transcriptomic,RNA-Seq,0.00405306024535024,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949103,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042565","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758647,Patient_48_AN_m0,SRA,"patient id: Patient_48,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758647,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",19249366,cDNA,transcriptomic,RNA-Seq,0.0031391276387336586,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949100,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042566","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758648,Patient_48_AL_m0,SRA,"patient id: Patient_48,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758648,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",19432099,cDNA,transcriptomic,RNA-Seq,0.0024585465116114696,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949099,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042567","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758649,Patient_49_AN_m0,SRA,"patient id: Patient_49,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758649,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",24853349,cDNA,transcriptomic,RNA-Seq,0.0036007320945408198,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949098,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042568","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758650,Patient_49_AL_m0,SRA,"patient id: Patient_49,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758650,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",30621774,cDNA,transcriptomic,RNA-Seq,0.0027244430158926336,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949097,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042569","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758651,Patient_50_AN_m0,SRA,"patient id: Patient_50,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758651,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",36321069,cDNA,transcriptomic,RNA-Seq,0.001961086177906927,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949096,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042570","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758652,Patient_50_AL_m0,SRA,"patient id: Patient_50,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758652,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",24168054,cDNA,transcriptomic,RNA-Seq,0.002189339154219697,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949095,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042571","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758653,Patient_51_AL_m0,SRA,"patient id: Patient_51,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758653,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",26021037,cDNA,transcriptomic,RNA-Seq,0.003794375189313361,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949235,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042572","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758654,Patient_51_AN_m0,SRA,"patient id: Patient_51,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758654,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",32024208,cDNA,transcriptomic,RNA-Seq,0.0011509298010239641,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949234,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042573","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758655,Patient_52_AL_m0,SRA,"patient id: Patient_52,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758655,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",22282180,cDNA,transcriptomic,RNA-Seq,-0.002327000861665588,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949233,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042574","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758656,Patient_52_AN_m0,SRA,"patient id: Patient_52,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758656,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",22995953,cDNA,transcriptomic,RNA-Seq,0.0012869366704478362,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949232,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042575","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758657,Patient_53_AN_m0,SRA,"patient id: Patient_53,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758657,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",23361666,cDNA,transcriptomic,RNA-Seq,-2.81485624689608e-05,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949231,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042576","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758658,Patient_53_AL_m0,SRA,"patient id: Patient_53,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758658,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",37025294,cDNA,transcriptomic,RNA-Seq,0.0032749357319341726,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949230,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042577","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758659,Patient_54_AL_m0,SRA,"patient id: Patient_54,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758659,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",33512199,cDNA,transcriptomic,RNA-Seq,0.0011509298010239641,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949229,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042578","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758660,Patient_55_AN_m0,SRA,"patient id: Patient_55,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758660,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",18289253,cDNA,transcriptomic,RNA-Seq,0.003112669089096994,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949228,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042579","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758661,Patient_55_AL_m0,SRA,"patient id: Patient_55,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758661,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",26069045,cDNA,transcriptomic,RNA-Seq,0.0005163930739464648,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949131,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042580","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758662,Patient_56_AL_m0,SRA,"patient id: Patient_56,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758662,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",28449727,cDNA,transcriptomic,RNA-Seq,0.0020617331568721217,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949130,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042581","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758663,Patient_56_AN_m0,SRA,"patient id: Patient_56,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758663,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",28178397,cDNA,transcriptomic,RNA-Seq,-0.0008288671646094357,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949129,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042582","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758664,Patient_57_AN_m0,SRA,"patient id: Patient_57,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AN,GSM4758664,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",23880558,cDNA,transcriptomic,RNA-Seq,0.00084103248331544,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949128,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042583","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758665,Patient_57_AL_m0,SRA,"patient id: Patient_57,disease state: atopic dermatitis,timepoint: baseline (m0),tissue: skin",m0_AL,GSM4758665,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",25168811,cDNA,transcriptomic,RNA-Seq,0.0009532095851253533,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949127,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042584","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758666,Patient_1_AL_m3,SRA,"patient id: Patient_1,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AL,GSM4758666,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",24620709,cDNA,transcriptomic,RNA-Seq,0.0028366201177025476,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949126,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042585","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758667,Patient_1_AN_m3,SRA,"patient id: Patient_1,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AN,GSM4758667,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",24060735,cDNA,transcriptomic,RNA-Seq,0.0023015162560296103,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949125,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042500","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758668,Patient_3_AL_m3,SRA,"patient id: Patient_3,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AL,GSM4758668,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",25801374,cDNA,transcriptomic,RNA-Seq,0.0023237372848339288,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949079,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042501","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758669,Patient_3_AN_m3,SRA,"patient id: Patient_3,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AN,GSM4758669,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",19476013,cDNA,transcriptomic,RNA-Seq,0.004456352544940926,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949078,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042502","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758670,Patient_4_AL_m3,SRA,"patient id: Patient_4,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: cyclosporine,tissue: skin",cyclosporine_m3_AL,GSM4758670,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",22909939,cDNA,transcriptomic,RNA-Seq,0.0029227079491172194,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949077,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042503","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758671,Patient_4_AN_m3,SRA,"patient id: Patient_4,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: cyclosporine,tissue: skin",cyclosporine_m3_AN,GSM4758671,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",24041555,cDNA,transcriptomic,RNA-Seq,0.0014391333996115923,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949076,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042504","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758672,Patient_8_AN_m3,SRA,"patient id: Patient_8,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: cyclosporine,tissue: skin",cyclosporine_m3_AN,GSM4758672,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",27812288,cDNA,transcriptomic,RNA-Seq,0.0007134264859678646,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949069,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042505","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758673,Patient_8_AL_m3,SRA,"patient id: Patient_8,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: cyclosporine,tissue: skin",cyclosporine_m3_AL,GSM4758673,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",30047789,cDNA,transcriptomic,RNA-Seq,0.000691205457163546,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949075,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042506","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758674,Patient_9_AN_m3,SRA,"patient id: Patient_9,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AN,GSM4758674,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",26938516,cDNA,transcriptomic,RNA-Seq,0.0038584775006798014,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949074,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042507","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758675,Patient_9_AL_m3,SRA,"patient id: Patient_9,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AL,GSM4758675,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",21716993,cDNA,transcriptomic,RNA-Seq,0.0038195960551346353,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949073,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042508","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758676,Patient_11_AN_m3,SRA,"patient id: Patient_11,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AN,GSM4758676,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",24354658,cDNA,transcriptomic,RNA-Seq,0.0016528272283738393,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949072,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042509","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758677,Patient_11_AL_m3,SRA,"patient id: Patient_11,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AL,GSM4758677,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",28154688,cDNA,transcriptomic,RNA-Seq,0.0027244430158926336,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949071,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042510","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758678,Patient_21_AN_m3,SRA,"patient id: Patient_21,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: cyclosporine,tissue: skin",cyclosporine_m3_AN,GSM4758678,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",24896331,cDNA,transcriptomic,RNA-Seq,0.0012869366704478362,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949070,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042511","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758679,Patient_21_AL_m3,SRA,"patient id: Patient_21,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: cyclosporine,tissue: skin",cyclosporine_m3_AL,GSM4758679,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",25512305,cDNA,transcriptomic,RNA-Seq,0.0022480756629339196,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949068,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042512","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758680,Patient_23_AN_m3,SRA,"patient id: Patient_23,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: cyclosporine,tissue: skin",cyclosporine_m3_AN,GSM4758680,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",26009338,cDNA,transcriptomic,RNA-Seq,0.002189339154219697,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949067,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042513","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758681,Patient_23_AL_m3,SRA,"patient id: Patient_23,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: cyclosporine,tissue: skin",cyclosporine_m3_AL,GSM4758681,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",25617892,cDNA,transcriptomic,RNA-Seq,0.0009416794622806347,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949066,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042514","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758682,Patient_24_AL_m3,SRA,"patient id: Patient_24,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: cyclosporine,tissue: skin",cyclosporine_m3_AL,GSM4758682,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",23025113,cDNA,transcriptomic,RNA-Seq,-0.00021838378512397695,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949065,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042515","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758683,Patient_24_AN_m3,SRA,"patient id: Patient_24,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: cyclosporine,tissue: skin",cyclosporine_m3_AN,GSM4758683,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",13681767,cDNA,transcriptomic,RNA-Seq,0.0056358816480131715,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949124,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042516","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758684,Patient_26_AN_m3,SRA,"patient id: Patient_26,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: cyclosporine,tissue: skin",cyclosporine_m3_AN,GSM4758684,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",28662940,cDNA,transcriptomic,RNA-Seq,0.0018334801805593515,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949123,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042517","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758685,Patient_26_AL_m3,SRA,"patient id: Patient_26,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: cyclosporine,tissue: skin",cyclosporine_m3_AL,GSM4758685,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",25022897,cDNA,transcriptomic,RNA-Seq,0.002219855422789038,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949122,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042518","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758686,Patient_28_AL_m3,SRA,"patient id: Patient_28,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AL,GSM4758686,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",22510930,cDNA,transcriptomic,RNA-Seq,0.0036007320945408198,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949121,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042519","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758687,Patient_28_AN_m3,SRA,"patient id: Patient_28,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AN,GSM4758687,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",24679834,cDNA,transcriptomic,RNA-Seq,0.00428131322166301,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949120,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042520","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758688,Patient_30_AN_m3,SRA,"patient id: Patient_30,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AN,GSM4758688,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",24795831,cDNA,transcriptomic,RNA-Seq,0.0016804156018218163,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949119,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042521","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758689,Patient_30_AL_m3,SRA,"patient id: Patient_30,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AL,GSM4758689,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",27622319,cDNA,transcriptomic,RNA-Seq,0.0016804156018218163,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949118,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042522","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758690,Patient_32_AL_m3,SRA,"patient id: Patient_32,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: cyclosporine,tissue: skin",cyclosporine_m3_AL,GSM4758690,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",22750403,cDNA,transcriptomic,RNA-Seq,0.0020317451137839364,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949117,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042523","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758691,Patient_32_AN_m3,SRA,"patient id: Patient_32,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: cyclosporine,tissue: skin",cyclosporine_m3_AN,GSM4758691,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",28870874,cDNA,transcriptomic,RNA-Seq,0.003517956383677301,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949116,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042524","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758692,Patient_34_AN_m3,SRA,"patient id: Patient_34,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AN,GSM4758692,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",25359262,cDNA,transcriptomic,RNA-Seq,0.0006662201000983588,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949115,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042525","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758693,Patient_34_AL_m3,SRA,"patient id: Patient_34,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AL,GSM4758693,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",32193844,cDNA,transcriptomic,RNA-Seq,0.001672229760511424,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949114,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042526","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758694,Patient_7_AN_m3,SRA,"patient id: Patient_7,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AN,GSM4758694,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",33710416,cDNA,transcriptomic,RNA-Seq,0.004329383299419928,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949113,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042527","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758695,Patient_7_AL_m3,SRA,"patient id: Patient_7,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AL,GSM4758695,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",20957959,cDNA,transcriptomic,RNA-Seq,0.004536501646103403,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949112,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042528","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758696,Patient_12_AN_m3,SRA,"patient id: Patient_12,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AN,GSM4758696,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",13089087,cDNA,transcriptomic,RNA-Seq,0.000744646050259235,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949111,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042529","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758697,Patient_12_AL_m3,SRA,"patient id: Patient_12,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AL,GSM4758697,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",29350151,cDNA,transcriptomic,RNA-Seq,0.0025624164706613615,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949110,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042530","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758698,Patient_13_AL_m3,SRA,"patient id: Patient_13,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AL,GSM4758698,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",25635167,cDNA,transcriptomic,RNA-Seq,0.0006170400529116596,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949033,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042531","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758699,Patient_13_AN_m3,SRA,"patient id: Patient_13,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AN,GSM4758699,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",28293355,cDNA,transcriptomic,RNA-Seq,0.002349682085352899,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949062,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042602","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758700,Patient_15_AL_m3,SRA,"patient id: Patient_15,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AL,GSM4758700,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",19762556,cDNA,transcriptomic,RNA-Seq,0.0028838265035720516,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949061,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042603","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758701,Patient_15_AN_m3,SRA,"patient id: Patient_15,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AN,GSM4758701,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",24048402,cDNA,transcriptomic,RNA-Seq,0.0027244430158926336,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949060,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042604","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758702,Patient_16_AL_m3,SRA,"patient id: Patient_16,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AL,GSM4758702,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",28017824,cDNA,transcriptomic,RNA-Seq,0.0016804156018218163,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949059,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042605","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758703,Patient_16_AN_m3,SRA,"patient id: Patient_16,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AN,GSM4758703,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",29919945,cDNA,transcriptomic,RNA-Seq,0.0031251087057822787,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949032,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042606","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758704,Patient_36_AL_m3,SRA,"patient id: Patient_36,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AL,GSM4758704,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",28530106,cDNA,transcriptomic,RNA-Seq,0.0038545182202090627,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949064,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042607","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758705,Patient_38_AL_m3,SRA,"patient id: Patient_38,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AL,GSM4758705,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",23485504,cDNA,transcriptomic,RNA-Seq,0.004441656152796213,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949063,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042608","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758706,Patient_39_AL_m3,SRA,"patient id: Patient_39,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AL,GSM4758706,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",31273474,cDNA,transcriptomic,RNA-Seq,0.0029437148643609032,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949058,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042609","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758707,Patient_39_AN_m3,SRA,"patient id: Patient_39,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AN,GSM4758707,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",34452460,cDNA,transcriptomic,RNA-Seq,0.0027244430158926336,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949057,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042610","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758708,Patient_40_AN_m3,SRA,"patient id: Patient_40,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AN,GSM4758708,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",29279768,cDNA,transcriptomic,RNA-Seq,0.0036040442150919727,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949056,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042611","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758709,Patient_40_AL_m3,SRA,"patient id: Patient_40,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AL,GSM4758709,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",30045471,cDNA,transcriptomic,RNA-Seq,0.004227096293622195,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949055,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042612","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758710,Patient_41_AL_m3,SRA,"patient id: Patient_41,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AL,GSM4758710,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",41777873,cDNA,transcriptomic,RNA-Seq,0.002238849205488016,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949054,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042613","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758711,Patient_41_AN_m3,SRA,"patient id: Patient_41,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AN,GSM4758711,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",30250468,cDNA,transcriptomic,RNA-Seq,0.0036040442150919727,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949053,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042614","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758712,Patient_42_AN_m3,SRA,"patient id: Patient_42,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AN,GSM4758712,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",30307159,cDNA,transcriptomic,RNA-Seq,0.004303671495061518,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949052,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042615","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758713,Patient_42_AL_m3,SRA,"patient id: Patient_42,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AL,GSM4758713,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",34082693,cDNA,transcriptomic,RNA-Seq,0.0013908327371330907,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949051,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042616","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758714,Patient_44_AL_m3,SRA,"patient id: Patient_44,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AL,GSM4758714,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",35156924,cDNA,transcriptomic,RNA-Seq,0.003982124217556637,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949050,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042617","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758715,Patient_44_AN_m3,SRA,"patient id: Patient_44,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AN,GSM4758715,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",30769990,cDNA,transcriptomic,RNA-Seq,0.0035401774124816194,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949094,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042548","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758716,Patient_46_AL_m3,SRA,"patient id: Patient_46,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AL,GSM4758716,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",17958802,cDNA,transcriptomic,RNA-Seq,0.003120812279748886,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949093,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042549","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758717,Patient_46_AN_m3,SRA,"patient id: Patient_46,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AN,GSM4758717,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",35079312,cDNA,transcriptomic,RNA-Seq,0.002339166180371591,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949092,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042550","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758718,Patient_48_AN_m3,SRA,"patient id: Patient_48,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AN,GSM4758718,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",20770916,cDNA,transcriptomic,RNA-Seq,0.001210880423298823,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949091,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042551","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758719,Patient_48_AL_m3,SRA,"patient id: Patient_48,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: dupilumab,tissue: skin",dupilumab_m3_AL,GSM4758719,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",50095664,cDNA,transcriptomic,RNA-Seq,-0.0012488199349006356,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949090,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042552","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4758720,Patient_54_AL_m3,SRA,"patient id: Patient_54,disease state: atopic dermatitis,timepoint: 3 months post-treatment (m3),therapy: cyclosporine,tissue: skin",cyclosporine_m3_AL,GSM4758720,GSE157194,polyA RNA,"RNAlater fixed skin tissue samples were disrupted using innuSPEED Lysis Tubes W (1.4 â 1.6 mm steel beads & 3.5 mm ceramic beads) (Analytik Jena, Jena, Germany) in a SpeedMill Plus (3x 1min intervals) (Analytik Jena) in Lysis/Binding Buffer (Lifetechnologies). Total RNA was isolated using the mirVanaTM miRNA Isolation Kit (Lifetechnologies, Carlsbad, CA) following the manufacturers specifications with an additional on-column DNase treatment.,RNA libraries were prepared for sequencing using standard Illumina protocols (TruSeq stranded mRNA)",28908142,cDNA,transcriptomic,RNA-Seq,0.0006170400529116596,Aug 31 2020,"Illumina bcl2fastq v2.20.0.422 software used for basecalling.,Illumina standard primers were trimmed using cutadapt (version 1.15),Reads were mapped to the human reference genome (GRCh38, Ensembl release 91) using Tophat2 (version 2.1.1) and Bowtie2 (version 2.3.2),Mapped reads were cleaned and sorted using Samtools (version 1.5),Number of reads for each gene was counted using HTSeq (version 0.10.0) and annotated according to the Gencode version 27 annotation gtf file,Genome_build: GRCh38, Ensembl release 91,Supplementary_files_format_and_content: Tab-delimited text file includes raw counts as generated by HTSeq",Public on Sep 01 2020,Sep 01 2020,1,Homo sapiens,9606,GPL21290,Illumina HiSeq 3000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN15949089,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9042553","Lena,,MÃ¶bus",Rosalind-Franklin-StraÃe 9,Kiel,,Germany,"University Hospital Schleswig-Holstein, Campus Kiel"
GSM4874231,Dermatitis_tape_NL (11),SRA,"individual: patient number 1,gender: M,age: 63,localization: hand,easi: 7,disease state: Atopic dermatitis,tissue: Stratum corneum,skin site: NL,sample type: tape",Skin layer,GSM4874231,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",8715341,cDNA,transcriptomic,RNA-Seq,0.04985674549860985,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605951,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9405990","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874232,Dermatitis_biopsy_dermis_L (110),SRA,"individual: patient number 1,gender: M,age: 63,localization: hand,easi: 7,disease state: Atopic dermatitis,tissue: Dermis,skin site: L,sample type: biopsy",Skin layer,GSM4874232,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",13549728,cDNA,transcriptomic,RNA-Seq,0.003969162109799362,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605950,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9405991","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874233,Dermatitis_tape_L (15),SRA,"individual: patient number 1,gender: M,age: 63,localization: hand,easi: 7,disease state: Atopic dermatitis,tissue: Stratum corneum,skin site: L,sample type: tape",Skin layer,GSM4874233,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",14052704,cDNA,transcriptomic,RNA-Seq,0.10244850224131583,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605949,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9405992","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874234,Dermatitis_biopsy_epidermis_L (19),SRA,"individual: patient number 1,gender: M,age: 63,localization: hand,easi: 7,disease state: Atopic dermatitis,tissue: Epidermis,skin site: L,sample type: biopsy",Skin layer,GSM4874234,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",19001801,cDNA,transcriptomic,RNA-Seq,0.0037149678355751486,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605948,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9405993","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874235,Dermatitis_tape_NL (21),SRA,"individual: patient number 2,gender: M,age: 53,localization: hand,easi: 23.1,disease state: Atopic dermatitis,tissue: Stratum corneum,skin site: NL,sample type: tape",Skin layer,GSM4874235,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",3933252,cDNA,transcriptomic,RNA-Seq,0.08266681861119961,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605947,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9405994","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874236,Dermatitis_biopsy_dermis_L (210),SRA,"individual: patient number 2,gender: M,age: 53,localization: hand,easi: 23.1,disease state: Atopic dermatitis,tissue: Dermis,skin site: L,sample type: biopsy",Skin layer,GSM4874236,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",8982320,cDNA,transcriptomic,RNA-Seq,0.012993957447015937,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605953,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9405995","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874237,Dermatitis_tape_L (25),SRA,"individual: patient number 2,gender: M,age: 53,localization: hand,easi: 23.1,disease state: Atopic dermatitis,tissue: Stratum corneum,skin site: L,sample type: tape",Skin layer,GSM4874237,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",8841235,cDNA,transcriptomic,RNA-Seq,0.0712082533892662,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605952,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9405996","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874238,Dermatitis_biopsy_epidermis_L (29),SRA,"individual: patient number 2,gender: M,age: 53,localization: hand,easi: 23.1,disease state: Atopic dermatitis,tissue: Epidermis,skin site: L,sample type: biopsy",Skin layer,GSM4874238,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",8742663,cDNA,transcriptomic,RNA-Seq,0.020842107733145446,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605946,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9405997","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874239,Dermatitis_biopsy_dermis_L (310),SRA,"individual: patient number 3,gender: F,age: 64,localization: hand,easi: 10.8,disease state: Atopic dermatitis,tissue: Dermis,skin site: L,sample type: biopsy",Skin layer,GSM4874239,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",14803975,cDNA,transcriptomic,RNA-Seq,0.042344898276292446,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605945,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9405998","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874240,Dermatitis_biopsy_epidermis_L (39),SRA,"individual: patient number 3,gender: F,age: 64,localization: hand,easi: 10.8,disease state: Atopic dermatitis,tissue: Epidermis,skin site: L,sample type: biopsy",Skin layer,GSM4874240,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",14348446,cDNA,transcriptomic,RNA-Seq,0.031185296916062206,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605926,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9405999","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874241,Dermatitis_tape_NL (41),SRA,"individual: patient number 4,gender: F,age: 27,localization: body,easi: 4.3,disease state: Atopic dermatitis,tissue: Stratum corneum,skin site: NL,sample type: tape",Skin layer,GSM4874241,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",13433402,cDNA,transcriptomic,RNA-Seq,0.13886796760862513,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605925,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406000","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874242,Dermatitis_biopsy_dermis_L (410),SRA,"individual: patient number 4,gender: F,age: 27,localization: body,easi: 4.3,disease state: Atopic dermatitis,tissue: Dermis,skin site: L,sample type: biopsy",Skin layer,GSM4874242,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",5207240,cDNA,transcriptomic,RNA-Seq,0.03294216814825123,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605924,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406001","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874243,Dermatitis_tape_L (45),SRA,"individual: patient number 4,gender: F,age: 27,localization: body,easi: 4.3,disease state: Atopic dermatitis,tissue: Stratum corneum,skin site: L,sample type: tape",Skin layer,GSM4874243,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",19913853,cDNA,transcriptomic,RNA-Seq,0.03888806330907588,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605923,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406002","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874244,Dermatitis_biopsy_epidermis_L (49),SRA,"individual: patient number 4,gender: F,age: 27,localization: body,easi: 4.3,disease state: Atopic dermatitis,tissue: Epidermis,skin site: L,sample type: biopsy",Skin layer,GSM4874244,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",7253711,cDNA,transcriptomic,RNA-Seq,0.026445645547898074,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605922,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406003","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874245,Dermatitis_tape_NL (51),SRA,"individual: patient number 5,gender: M,age: 23,localization: body,easi: 19.8,disease state: Atopic dermatitis,tissue: Stratum corneum,skin site: NL,sample type: tape",Skin layer,GSM4874245,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",14168401,cDNA,transcriptomic,RNA-Seq,0.10952098528840287,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605921,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406004","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874246,Dermatitis_biopsy_dermis_L (510),SRA,"individual: patient number 5,gender: M,age: 23,localization: body,easi: 19.8,disease state: Atopic dermatitis,tissue: Dermis,skin site: L,sample type: biopsy",Skin layer,GSM4874246,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",7871979,cDNA,transcriptomic,RNA-Seq,0.03331389793214021,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605920,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406005","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874247,Dermatitis_tape_L (55),SRA,"individual: patient number 5,gender: M,age: 23,localization: body,easi: 19.8,disease state: Atopic dermatitis,tissue: Stratum corneum,skin site: L,sample type: tape",Skin layer,GSM4874247,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",17661751,cDNA,transcriptomic,RNA-Seq,0.07897022785686468,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605919,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406006","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874248,Dermatitis_biopsy_epidermis_L (59),SRA,"individual: patient number 5,gender: M,age: 23,localization: body,easi: 19.8,disease state: Atopic dermatitis,tissue: Epidermis,skin site: L,sample type: biopsy",Skin layer,GSM4874248,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",7144178,cDNA,transcriptomic,RNA-Seq,0.013534205953521767,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605918,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406007","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874249,Dermatitis_tape_NL (61),SRA,"individual: patient number 6,gender: F,age: 57,localization: hand,easi: 1,disease state: Atopic dermatitis,tissue: Stratum corneum,skin site: NL,sample type: tape",Skin layer,GSM4874249,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",3928382,cDNA,transcriptomic,RNA-Seq,0.032804809010541704,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605917,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406008","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874250,Dermatitis_biopsy_dermis_L (610),SRA,"individual: patient number 6,gender: F,age: 57,localization: hand,easi: 1,disease state: Atopic dermatitis,tissue: Dermis,skin site: L,sample type: biopsy",Skin layer,GSM4874250,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",33612798,cDNA,transcriptomic,RNA-Seq,0.034118543222083346,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605916,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406009","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874251,Dermatitis_tape_L (65),SRA,"individual: patient number 6,gender: F,age: 57,localization: hand,easi: 1,disease state: Atopic dermatitis,tissue: Stratum corneum,skin site: L,sample type: tape",Skin layer,GSM4874251,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",13637332,cDNA,transcriptomic,RNA-Seq,0.09015695055999454,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605915,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406010","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874252,Dermatitis_biopsy_epidermis_L (69),SRA,"individual: patient number 6,gender: F,age: 57,localization: hand,easi: 1,disease state: Atopic dermatitis,tissue: Epidermis,skin site: L,sample type: biopsy",Skin layer,GSM4874252,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",12578090,cDNA,transcriptomic,RNA-Seq,0.03158596260595185,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605914,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406011","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874253,Dermatitis_tape_NL (71),SRA,"individual: patient number 7,gender: M,age: 52,localization: hand,easi: 1.6,disease state: Atopic dermatitis,tissue: Stratum corneum,skin site: NL,sample type: tape",Skin layer,GSM4874253,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",6619455,cDNA,transcriptomic,RNA-Seq,0.06466948784799928,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605944,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406012","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874254,Dermatitis_biopsy_dermis_L (710),SRA,"individual: patient number 7,gender: M,age: 52,localization: hand,easi: 1.6,disease state: Atopic dermatitis,tissue: Dermis,skin site: L,sample type: biopsy",Skin layer,GSM4874254,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",5946476,cDNA,transcriptomic,RNA-Seq,0.06725942817987504,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605943,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406013","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874255,Dermatitis_tape_L (75),SRA,"individual: patient number 7,gender: M,age: 52,localization: hand,easi: 1.6,disease state: Atopic dermatitis,tissue: Stratum corneum,skin site: L,sample type: tape",Skin layer,GSM4874255,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",7462524,cDNA,transcriptomic,RNA-Seq,0.03627055784346945,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605942,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406014","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874256,Dermatitis_biopsy_epidermis_L (79),SRA,"individual: patient number 7,gender: M,age: 52,localization: hand,easi: 1.6,disease state: Atopic dermatitis,tissue: Epidermis,skin site: L,sample type: biopsy",Skin layer,GSM4874256,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",9625846,cDNA,transcriptomic,RNA-Seq,0.04478257295884391,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605941,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406015","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874257,Dermatitis_biopsy_dermis_L (810),SRA,"individual: patient number 8,gender: M,age: 43,localization: body,easi: 21.8,disease state: Atopic dermatitis,tissue: Dermis,skin site: L,sample type: biopsy",Skin layer,GSM4874257,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",9134657,cDNA,transcriptomic,RNA-Seq,0.000208072059586792,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605940,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406016","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874258,Dermatitis_tape_L (85),SRA,"individual: patient number 8,gender: M,age: 43,localization: body,easi: 21.8,disease state: Atopic dermatitis,tissue: Stratum corneum,skin site: L,sample type: tape",Skin layer,GSM4874258,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",10738832,cDNA,transcriptomic,RNA-Seq,0.1341950238706388,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605939,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406017","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874259,Dermatitis_biopsy_epidermis_L (89),SRA,"individual: patient number 8,gender: M,age: 43,localization: body,easi: 21.8,disease state: Atopic dermatitis,tissue: Epidermis,skin site: L,sample type: biopsy",Skin layer,GSM4874259,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",14719048,cDNA,transcriptomic,RNA-Seq,0.01756007277905099,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605938,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406018","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874260,Dermatitis_tape_NL (101),SRA,"individual: patient number 10,gender: F,age: 20,localization: hand,easi: 2.3,disease state: Atopic dermatitis,tissue: Stratum corneum,skin site: NL,sample type: tape",Skin layer,GSM4874260,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",11430773,cDNA,transcriptomic,RNA-Seq,-0.03524338533306167,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605937,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406019","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874261,Dermatitis_biopsy_dermis_L (1010),SRA,"individual: patient number 10,gender: F,age: 20,localization: hand,easi: 2.3,disease state: Atopic dermatitis,tissue: Dermis,skin site: L,sample type: biopsy",Skin layer,GSM4874261,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",7021459,cDNA,transcriptomic,RNA-Seq,0.0636562196883712,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605936,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406020","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874262,Dermatitis_tape_L (105),SRA,"individual: patient number 10,gender: F,age: 20,localization: hand,easi: 2.3,disease state: Atopic dermatitis,tissue: Stratum corneum,skin site: L,sample type: tape",Skin layer,GSM4874262,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",8165006,cDNA,transcriptomic,RNA-Seq,0.06326085492386811,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605935,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406021","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM4874263,Dermatitis_biopsy_epidermis_L (109),SRA,"individual: patient number 10,gender: F,age: 20,localization: hand,easi: 2.3,disease state: Atopic dermatitis,tissue: Epidermis,skin site: L,sample type: biopsy",Skin layer,GSM4874263,GSE160501,total RNA,"Total RNA was extracted using the Exiqon miRCURYâ¢ RNA Isolation Kit - Cell and Plant (Exiqon, now Qiagen Denmark, Copenhagen, Denmark) following the manufacturerâs recommendation, with additional heating of the lysis buffer to 56Â°C for 5 min before adding 70% ethanol (Qiagen Denmark, Copenhagen, Denmark).,Library preparation was performed with the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian kit (Takara Bio Europe, Saint-Germain-en-Laye, France) following the manufacturerâs recommendation without fragmentation. To capture all RNA transcripts, the kit uses random hexamer primers for amplification. The protocol included removal of ribosomal RNA. For comparability, the same protocol was used for all sample types.,Single-end sequencing (75 bp) was performed with a NextSeq 500 (Illumina Denmark, Copenhagen, Denmark)",7244050,cDNA,transcriptomic,RNA-Seq,0.04085829973321325,Oct 30 2020,"BCL files were converted to FASTQ files with the bcl2fastq software (Illumina, California, USA),Adapters as well as consecutive stretches of low-quality bases (Q<30) from the 5â and 3â termini were removed using AdapterRemoval version 2.1.3.  A length threshold of 20 bp was used for read removal.,Reads were aligned using STAR (Spliced Transcripts Alignment to a Reference) version 2.5.3a with default settings  where reads with multiple alignment were discarded.,Genome_build: For alignment, the Gene transfer format (GTF) annotation file for the hg38 reference genome (from the GENCODE consortium release 27) were used.,Supplementary_files_format_and_content: One processed .txt matrix containing Deseq2 normalized abundance data for all samples. One non-lesional tape sample was excluded due to low number of reads (<0.5M), and another lesional and non-lesional tape sample were excluded due to contamination of the samples.  The excluded samples are: 31, 35, 81 (not included in this GEO study).",Public on Oct 31 2020,Nov 02 2020,1,Homo sapiens,9606,GPL18573,Illumina NextSeq 500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN16605934,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX9406022","Julie,Breinholt KjÃ¦r,SÃ¸lberg",Gentofte Hospitalsvej 20A,Hellerup,,Denmark,The national allergy research centre
GSM5362072,Skin-atopic dermatitis lesion-01,SRA,"disease state: atopic dermatitis,tissue: skin (epidermis+dermis),age (yr-old): 20",human skin,GSM5362072,GSE176279,polyA RNA,"RNA extract from epidermis and skin, flash frozen on dry ice, and RNA was harvested using Trizol reagent. Illumina TruSeq RNA Sample Prep Kit was used with 1 ug of total RNA for the construction of sequencing libraries.,RNA libraries were prepared for sequencing using standard Illumina protocols",39323124,cDNA,transcriptomic,RNA-Seq,0.0035817866172943406,Jun 07 2021,"To separate human RNA seq reads, we used bbpsplit including bbmap package(https://sourceforge.net/projects/bbmap/),Low quality reads were filtered according to the following criteria; N-ratio > 0.1 and ratio of less than Phred quality score 20 > 0.4,Filtered reads were mapped to the human reference genome (Ensembl release 72) using the aligner STAR v.2.3.0e.,Gene expression level was measured with Cufflinks v2.1.1 (Trapnell C. et al, 2010) using the gene annotation database of Ensembl release 72.,For differential expression analysis, gene level count data were generated using HTSeq-count v0.5.4p3 (Anders S. et al, 20140) tool with the option ""-m intersection-nonemptyâ and -r option considering paired-end sequence.,Genome_build: mm9,Supplementary_files_format_and_content: To characterize the identified genes from DEG analysis, GO based trend test was performed using the Fisherâs exact test",Public on Jun 08 2021,Jun 08 2021,1,Homo sapiens,9606,GPL16791,Illumina HiSeq 2500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN19594096,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX11083559","Seung-Phil,,Hong",20 Ilsan-ro,Wonju,,South Korea,Yonsei University Wonju College of Medicine
GSM5362073,Skin-atopic dermatitis lesion-02,SRA,"disease state: atopic dermatitis,tissue: skin (epidermis+dermis),age (yr-old): 23",human skin,GSM5362073,GSE176279,polyA RNA,"RNA extract from epidermis and skin, flash frozen on dry ice, and RNA was harvested using Trizol reagent. Illumina TruSeq RNA Sample Prep Kit was used with 1 ug of total RNA for the construction of sequencing libraries.,RNA libraries were prepared for sequencing using standard Illumina protocols",35260047,cDNA,transcriptomic,RNA-Seq,0.004752687525319785,Jun 07 2021,"To separate human RNA seq reads, we used bbpsplit including bbmap package(https://sourceforge.net/projects/bbmap/),Low quality reads were filtered according to the following criteria; N-ratio > 0.1 and ratio of less than Phred quality score 20 > 0.4,Filtered reads were mapped to the human reference genome (Ensembl release 72) using the aligner STAR v.2.3.0e.,Gene expression level was measured with Cufflinks v2.1.1 (Trapnell C. et al, 2010) using the gene annotation database of Ensembl release 72.,For differential expression analysis, gene level count data were generated using HTSeq-count v0.5.4p3 (Anders S. et al, 20140) tool with the option ""-m intersection-nonemptyâ and -r option considering paired-end sequence.,Genome_build: mm9,Supplementary_files_format_and_content: To characterize the identified genes from DEG analysis, GO based trend test was performed using the Fisherâs exact test",Public on Jun 08 2021,Jun 08 2021,1,Homo sapiens,9606,GPL16791,Illumina HiSeq 2500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN19594095,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX11083560","Seung-Phil,,Hong",20 Ilsan-ro,Wonju,,South Korea,Yonsei University Wonju College of Medicine
GSM5492118,HPS0270_rep1,SRA,"cell type: iPSC,disease state: Atopic dermatitis,treatment: untreated,derived from: PBMC/T",iPSC,GSM5492118,GSE181180,polyA RNA,"RNA was harvested from cell using RLT plus 2-mercaptethanol reagent. Illumina TruSeq stranded mRNA Library Prep Kit was used with 350 ng of total RNA for the construction of sequencing libraries.,RNA libraries were prepared for sequencing using standard Illumina protocols.",4561921,cDNA,transcriptomic,RNA-Seq,0.011631700934723436,Jul 30 2021,"Reads were trimmed by TrimGalore-0.6.6,Reads were aligned to human reference genome using tophat2 v2.1.1 with bowtie2 v2.2.5,gene counts were generated by featureCounts v1.5.0-p2,Genome_build: GRCh38,Supplementary_files_format_and_content: tab-delimited text files include gene counts for each Sample",Public on Aug 04 2021,Aug 04 2021,1,Homo sapiens,9606,GPL16791,Illumina HiSeq 2500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN20501397,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX11609839","Ying,,Chen","53 Kawahara-cho, Shogoin, Sakyo-ku",Kyoto,,Japan,"Center for iPS Cell Research and Application, Kyoto University"
GSM5492119,HPS0270_rep2,SRA,"cell type: iPSC,disease state: Atopic dermatitis,treatment: untreated,derived from: PBMC/T",iPSC,GSM5492119,GSE181180,polyA RNA,"RNA was harvested from cell using RLT plus 2-mercaptethanol reagent. Illumina TruSeq stranded mRNA Library Prep Kit was used with 350 ng of total RNA for the construction of sequencing libraries.,RNA libraries were prepared for sequencing using standard Illumina protocols.",3375829,cDNA,transcriptomic,RNA-Seq,0.009091391973590495,Jul 30 2021,"Reads were trimmed by TrimGalore-0.6.6,Reads were aligned to human reference genome using tophat2 v2.1.1 with bowtie2 v2.2.5,gene counts were generated by featureCounts v1.5.0-p2,Genome_build: GRCh38,Supplementary_files_format_and_content: tab-delimited text files include gene counts for each Sample",Public on Aug 04 2021,Aug 04 2021,1,Homo sapiens,9606,GPL16791,Illumina HiSeq 2500,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN20501398,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX11609840","Ying,,Chen","53 Kawahara-cho, Shogoin, Sakyo-ku",Kyoto,,Japan,"Center for iPS Cell Research and Application, Kyoto University"
GSM6252915,"Patient 2 non lesional atopic dermatitis, rep 1 [P16357_1001]",SRA,"tissue: skin,disease: atopic dermatitis,tissue type: non lesional,patient: 2",skin,GSM6252915,GSE206391,total RNA,"Upon cryosectioning, samples were equilibrated to cryostat chamber temperature and covered in optimal cutting temperature compound. Sections were taken at 10 Âµm thickness and directly placed onto the Visium Spatial Gene Expression slide (10x Genomics). Slides were processed using the Visium Spatial Gene Expression Kit (10x Genomics) following the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA.,Libraries were constructed following the the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA by 10x Genomics.",76202083,cDNA,transcriptomic,RNA-Seq,0.45374271743517464,Jun 17 2022,"Spots were partially manually aligned and data was processed using the Space Ranger Software v1.0.0 from 10x Genomics,Assembly: hg38_ensrel99,Supplementary files format and content: .h5 files",Public on Nov 14 2022,Apr 19 2023,1,Homo sapiens,9606,GPL24676,Illumina NovaSeq 6000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN29180830,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX15783401","Christina,,Hillig",Ingolstaedter LandstraÃe 1,Munich,,Germany,Helmholtz Center Munich
GSM6252916,"Patient 2 non lesional atopic dermatitis, rep 2 [P16357_1002]",SRA,"tissue: skin,disease: atopic dermatitis,tissue type: non lesional,patient: 2",skin,GSM6252916,GSE206391,total RNA,"Upon cryosectioning, samples were equilibrated to cryostat chamber temperature and covered in optimal cutting temperature compound. Sections were taken at 10 Âµm thickness and directly placed onto the Visium Spatial Gene Expression slide (10x Genomics). Slides were processed using the Visium Spatial Gene Expression Kit (10x Genomics) following the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA.,Libraries were constructed following the the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA by 10x Genomics.",73906800,cDNA,transcriptomic,RNA-Seq,0.20534611120041055,Jun 17 2022,"Spots were partially manually aligned and data was processed using the Space Ranger Software v1.0.0 from 10x Genomics,Assembly: hg38_ensrel99,Supplementary files format and content: .h5 files",Public on Nov 14 2022,Apr 19 2023,1,Homo sapiens,9606,GPL24676,Illumina NovaSeq 6000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN29180831,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX15783402","Christina,,Hillig",Ingolstaedter LandstraÃe 1,Munich,,Germany,Helmholtz Center Munich
GSM6252928,"Patient 5 non lesional atopic dermatitis, rep 2 [P16357_1014]",SRA,"tissue: skin,disease: atopic dermatitis,tissue type: non lesional,patient: 5",skin,GSM6252928,GSE206391,total RNA,"Upon cryosectioning, samples were equilibrated to cryostat chamber temperature and covered in optimal cutting temperature compound. Sections were taken at 10 Âµm thickness and directly placed onto the Visium Spatial Gene Expression slide (10x Genomics). Slides were processed using the Visium Spatial Gene Expression Kit (10x Genomics) following the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA.,Libraries were constructed following the the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA by 10x Genomics.",78898804,cDNA,transcriptomic,RNA-Seq,0.4590363619502715,Jun 17 2022,"Spots were partially manually aligned and data was processed using the Space Ranger Software v1.0.0 from 10x Genomics,Assembly: hg38_ensrel99,Supplementary files format and content: .h5 files",Public on Nov 14 2022,Apr 19 2023,1,Homo sapiens,9606,GPL24676,Illumina NovaSeq 6000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN29180824,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX15783414","Christina,,Hillig",Ingolstaedter LandstraÃe 1,Munich,,Germany,Helmholtz Center Munich
GSM6252930,"Patient 5 lesional atopic dermatitis, rep 2 [P16357_1016]",SRA,"tissue: skin,disease: atopic dermatitis,tissue type: lesional,patient: 5",skin,GSM6252930,GSE206391,total RNA,"Upon cryosectioning, samples were equilibrated to cryostat chamber temperature and covered in optimal cutting temperature compound. Sections were taken at 10 Âµm thickness and directly placed onto the Visium Spatial Gene Expression slide (10x Genomics). Slides were processed using the Visium Spatial Gene Expression Kit (10x Genomics) following the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA.,Libraries were constructed following the the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA by 10x Genomics.",84733547,cDNA,transcriptomic,RNA-Seq,0.35356540779166595,Jun 17 2022,"Spots were partially manually aligned and data was processed using the Space Ranger Software v1.0.0 from 10x Genomics,Assembly: hg38_ensrel99,Supplementary files format and content: .h5 files",Public on Nov 14 2022,Apr 19 2023,1,Homo sapiens,9606,GPL24676,Illumina NovaSeq 6000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN29180841,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX15783416","Christina,,Hillig",Ingolstaedter LandstraÃe 1,Munich,,Germany,Helmholtz Center Munich
GSM6252939,"Patient 8 non lesional atopic dermatitis, rep 1 [P16357_1025]",SRA,"tissue: skin,disease: atopic dermatitis,tissue type: non lesional,patient: 8",skin,GSM6252939,GSE206391,total RNA,"Upon cryosectioning, samples were equilibrated to cryostat chamber temperature and covered in optimal cutting temperature compound. Sections were taken at 10 Âµm thickness and directly placed onto the Visium Spatial Gene Expression slide (10x Genomics). Slides were processed using the Visium Spatial Gene Expression Kit (10x Genomics) following the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA.,Libraries were constructed following the the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA by 10x Genomics.",204743746,cDNA,transcriptomic,RNA-Seq,0.28668017180944777,Jun 17 2022,"Spots were partially manually aligned and data was processed using the Space Ranger Software v1.0.0 from 10x Genomics,Assembly: hg38_ensrel99,Supplementary files format and content: .h5 files",Public on Nov 14 2022,Apr 19 2023,1,Homo sapiens,9606,GPL24676,Illumina NovaSeq 6000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN29180793,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX15783425","Christina,,Hillig",Ingolstaedter LandstraÃe 1,Munich,,Germany,Helmholtz Center Munich
GSM6252940,"Patient 8 non lesional atopic dermatitis, rep 2 [P16357_1026]",SRA,"tissue: skin,disease: atopic dermatitis,tissue type: non lesional,patient: 8",skin,GSM6252940,GSE206391,total RNA,"Upon cryosectioning, samples were equilibrated to cryostat chamber temperature and covered in optimal cutting temperature compound. Sections were taken at 10 Âµm thickness and directly placed onto the Visium Spatial Gene Expression slide (10x Genomics). Slides were processed using the Visium Spatial Gene Expression Kit (10x Genomics) following the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA.,Libraries were constructed following the the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA by 10x Genomics.",86385229,cDNA,transcriptomic,RNA-Seq,0.21810523600682505,Jun 17 2022,"Spots were partially manually aligned and data was processed using the Space Ranger Software v1.0.0 from 10x Genomics,Assembly: hg38_ensrel99,Supplementary files format and content: .h5 files",Public on Nov 14 2022,Apr 19 2023,1,Homo sapiens,9606,GPL24676,Illumina NovaSeq 6000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN29180797,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX15783426","Christina,,Hillig",Ingolstaedter LandstraÃe 1,Munich,,Germany,Helmholtz Center Munich
GSM6252941,"Patient 8 lesional atopic dermatitis, rep 1 [P16357_1027]",SRA,"tissue: skin,disease: atopic dermatitis,tissue type: lesional,patient: 8",skin,GSM6252941,GSE206391,total RNA,"Upon cryosectioning, samples were equilibrated to cryostat chamber temperature and covered in optimal cutting temperature compound. Sections were taken at 10 Âµm thickness and directly placed onto the Visium Spatial Gene Expression slide (10x Genomics). Slides were processed using the Visium Spatial Gene Expression Kit (10x Genomics) following the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA.,Libraries were constructed following the the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA by 10x Genomics.",218092041,cDNA,transcriptomic,RNA-Seq,0.4711019758206555,Jun 17 2022,"Spots were partially manually aligned and data was processed using the Space Ranger Software v1.0.0 from 10x Genomics,Assembly: hg38_ensrel99,Supplementary files format and content: .h5 files",Public on Nov 14 2022,Apr 19 2023,1,Homo sapiens,9606,GPL24676,Illumina NovaSeq 6000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN29180794,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX15783427","Christina,,Hillig",Ingolstaedter LandstraÃe 1,Munich,,Germany,Helmholtz Center Munich
GSM6252952,"Patient 11 non lesional atopic dermatitis, rep 2 [P16357_1038]",SRA,"tissue: skin,disease: atopic dermatitis,tissue type: non lesional,patient: 11",skin,GSM6252952,GSE206391,total RNA,"Upon cryosectioning, samples were equilibrated to cryostat chamber temperature and covered in optimal cutting temperature compound. Sections were taken at 10 Âµm thickness and directly placed onto the Visium Spatial Gene Expression slide (10x Genomics). Slides were processed using the Visium Spatial Gene Expression Kit (10x Genomics) following the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA.,Libraries were constructed following the the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA by 10x Genomics.",54951153,cDNA,transcriptomic,RNA-Seq,0.06299442018716636,Jun 17 2022,"Spots were partially manually aligned and data was processed using the Space Ranger Software v1.0.0 from 10x Genomics,Assembly: hg38_ensrel99,Supplementary files format and content: .h5 files",Public on Nov 14 2022,Apr 19 2023,1,Homo sapiens,9606,GPL24676,Illumina NovaSeq 6000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN29180806,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX15783438","Christina,,Hillig",Ingolstaedter LandstraÃe 1,Munich,,Germany,Helmholtz Center Munich
GSM6252953,"Patient 11 lesional atopic dermatitis, rep 1 [P16357_1039]",SRA,"tissue: skin,disease: atopic dermatitis,tissue type: lesional,patient: 11",skin,GSM6252953,GSE206391,total RNA,"Upon cryosectioning, samples were equilibrated to cryostat chamber temperature and covered in optimal cutting temperature compound. Sections were taken at 10 Âµm thickness and directly placed onto the Visium Spatial Gene Expression slide (10x Genomics). Slides were processed using the Visium Spatial Gene Expression Kit (10x Genomics) following the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA.,Libraries were constructed following the the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA by 10x Genomics.",131043364,cDNA,transcriptomic,RNA-Seq,0.21754252466942234,Jun 17 2022,"Spots were partially manually aligned and data was processed using the Space Ranger Software v1.0.0 from 10x Genomics,Assembly: hg38_ensrel99,Supplementary files format and content: .h5 files",Public on Nov 14 2022,Apr 19 2023,1,Homo sapiens,9606,GPL24676,Illumina NovaSeq 6000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN29180807,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX15783439","Christina,,Hillig",Ingolstaedter LandstraÃe 1,Munich,,Germany,Helmholtz Center Munich
GSM6252954,"Patient 11 lesional atopic dermatitis, rep 2 [P16357_1040]",SRA,"tissue: skin,disease: atopic dermatitis,tissue type: lesional,patient: 11",skin,GSM6252954,GSE206391,total RNA,"Upon cryosectioning, samples were equilibrated to cryostat chamber temperature and covered in optimal cutting temperature compound. Sections were taken at 10 Âµm thickness and directly placed onto the Visium Spatial Gene Expression slide (10x Genomics). Slides were processed using the Visium Spatial Gene Expression Kit (10x Genomics) following the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA.,Libraries were constructed following the the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA by 10x Genomics.",139049700,cDNA,transcriptomic,RNA-Seq,0.3797609689953696,Jun 17 2022,"Spots were partially manually aligned and data was processed using the Space Ranger Software v1.0.0 from 10x Genomics,Assembly: hg38_ensrel99,Supplementary files format and content: .h5 files",Public on Nov 14 2022,Apr 19 2023,1,Homo sapiens,9606,GPL24676,Illumina NovaSeq 6000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN29180808,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX15783440","Christina,,Hillig",Ingolstaedter LandstraÃe 1,Munich,,Germany,Helmholtz Center Munich
GSM6252967,"Patient 15 lesional atopic dermatitis, rep 1 [P16357_1053]",SRA,"tissue: skin,disease: atopic dermatitis,tissue type: lesional,patient: 15",skin,GSM6252967,GSE206391,total RNA,"Upon cryosectioning, samples were equilibrated to cryostat chamber temperature and covered in optimal cutting temperature compound. Sections were taken at 10 Âµm thickness and directly placed onto the Visium Spatial Gene Expression slide (10x Genomics). Slides were processed using the Visium Spatial Gene Expression Kit (10x Genomics) following the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA.,Libraries were constructed following the the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA by 10x Genomics.",53018144,cDNA,transcriptomic,RNA-Seq,0.30621674672896476,Jun 17 2022,"Spots were partially manually aligned and data was processed using the Space Ranger Software v1.0.0 from 10x Genomics,Assembly: hg38_ensrel99,Supplementary files format and content: .h5 files",Public on Nov 14 2022,Apr 19 2023,1,Homo sapiens,9606,GPL24676,Illumina NovaSeq 6000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN29180821,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX15783453","Christina,,Hillig",Ingolstaedter LandstraÃe 1,Munich,,Germany,Helmholtz Center Munich
GSM6252968,"Patient 15 lesional atopic dermatitis, rep 2 [P16357_1054]",SRA,"tissue: skin,disease: atopic dermatitis,tissue type: lesional,patient: 15",skin,GSM6252968,GSE206391,total RNA,"Upon cryosectioning, samples were equilibrated to cryostat chamber temperature and covered in optimal cutting temperature compound. Sections were taken at 10 Âµm thickness and directly placed onto the Visium Spatial Gene Expression slide (10x Genomics). Slides were processed using the Visium Spatial Gene Expression Kit (10x Genomics) following the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA.,Libraries were constructed following the the CG000239 Visium Spatial Gene Expression Reagent Kits - User Guide RevA by 10x Genomics.",65654311,cDNA,transcriptomic,RNA-Seq,0.2057410105347243,Jun 17 2022,"Spots were partially manually aligned and data was processed using the Space Ranger Software v1.0.0 from 10x Genomics,Assembly: hg38_ensrel99,Supplementary files format and content: .h5 files",Public on Nov 14 2022,Apr 19 2023,1,Homo sapiens,9606,GPL24676,Illumina NovaSeq 6000,"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN29180781,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX15783454","Christina,,Hillig",Ingolstaedter LandstraÃe 1,Munich,,Germany,Helmholtz Center Munich
